<SEC-DOCUMENT>0001193125-21-100219.txt : 20210330
<SEC-HEADER>0001193125-21-100219.hdr.sgml : 20210330
<ACCEPTANCE-DATETIME>20210330164552
ACCESSION NUMBER:		0001193125-21-100219
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210511
FILED AS OF DATE:		20210330
DATE AS OF CHANGE:		20210330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		21786594

	BUSINESS ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d137834ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>ACHIEVE LIFE SCIENCES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified in its Charter) </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">No fee required</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
<FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-before:always; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACHIEVE LIFE SCIENCES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1040 West Georgia Street, Suite 1030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Vancouver, British Columbia, Canada V6E 4H1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Achieve Life Sciences, Inc., a Delaware corporation, will be held on May&nbsp;11, 2021, at
12:00 p.m. Pacific time. In light of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and as part of our effort to maintain a safe and healthy environment for our directors, members of management and stockholders, stockholders are requested not to
attend the Annual Meeting in person and instead to submit Forms of Proxy, appointing the Chief Executive Officer or Chairman of the Board (or their substitute(s)), to ensure they can vote and be represented at the Annual Meeting without attending in
person. Proxy voting can be done in advance of the Annual Meeting. For further instructions on remote voting, please see your Proxy Card enclosed. If you wish to listen live to the Annual Meeting the webcast can be accessed at
<U>https://www.webcaster4.com/Webcast/Page/2636/40168</U>. Alternatively, you may access the live Annual Meeting by dialing <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-407-8133</FONT></FONT> (U.S. &amp; Canada) or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">201-689-8040</FONT></FONT> (International). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual Meeting will be held for the following
purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To elect seven directors to serve until our next annual meeting of stockholders or until their successors are
duly elected and qualified; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To ratify the appointment of PricewaterhouseCoopers LLP, or PwC, as our independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To transact such other business as may properly come before the Annual Meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on March&nbsp;15, 2021 are entitled to notice of, and to vote at, the Annual Meeting. For 10 days prior
to the Annual Meeting, a complete list of stockholders entitled to vote at the Annual Meeting will be available for examination by any stockholder, for any purpose relating to the Annual Meeting, during ordinary business hours at our principal
executive office at the above address. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors, </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:55%; text-indent:-2%">


<IMG SRC="g137834g30h04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">John Bencich </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Chief Executive Officer </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vancouver, British Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;30, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>Whether or not you plan to attend the Annual Meeting virtually, we encourage you to vote and submit your
proxy by telephone, via the Internet or by mail. For additional instructions on attending virtually, voting by telephone or via the Internet, please refer to the proxy card. To vote and submit your proxy by mail, please complete, sign and date the
enclosed proxy card and return it in the enclosed envelope. If you hold your shares through an account with a brokerage firm, bank or other nominee, please follow the instructions you receive from them to vote your shares. </B></P></div>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY&nbsp;11, 2021
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Company&#146;s Proxy Statement and Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>December&nbsp;31, 2020 are available at ir.achievelifesciences.com. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_1">BOARD OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_2">PROPOSAL ONE: ELECTION OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_3">REPORT OF THE AUDIT COMMITTEE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_4">PROPOSAL TWO: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
 FIRM</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_5">EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_6">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_7">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc137834_8">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACHIEVE LIFE SCIENCES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1040 West Georgia Street, Suite 1030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Vancouver, British Columbia, Canada V6E 4H1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT FOR </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement for the Annual Meeting, or Proxy Statement, is furnished in connection with the solicitation of proxies on behalf of the board of
directors, or Board of Directors or Board, of Achieve Life Sciences, Inc., a Delaware corporation, or the Company, for use at the Annual Meeting of Stockholders, or the Annual Meeting, to be held on May&nbsp;11, 2021, at 12:00 p.m. Pacific time for
the purposes set forth in this Proxy Statement and in the accompanying Notice of Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> and to adhere to the continuing public health directives in relation to <FONT STYLE="white-space:nowrap">non-essential</FONT> travel and public gatherings, and to support the health and well-being of
our partners and stockholders, we ask that stockholders submit their proxy by telephone, via the Internet or by mail. You will not be able to attend the Annual Meeting in person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This Proxy Statement and accompanying proxy card will first be mailed on or about March&nbsp;30, 2021 to all stockholders entitled to vote at the Annual
Meeting. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of
record at the close of business on March&nbsp;15, 2021, the record date, are entitled to notice of and to vote at the Annual Meeting and any adjournment or postponement of the Annual Meeting. At the close of business on March&nbsp;15, 2021, we had
6,149,917 shares of common stock outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each stockholder of record is entitled to one vote for each share of common stock held on the record date
on all matters. Dissenters&#146; rights are not applicable to any of the matters being voted on. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participating in the Annual Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will be hosting the Annual Meeting live via Internet webcast. You will not be able to attend the meeting in person. A summary of the information you need to
participate in the Annual Meeting online is provided below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any stockholder may listen to the Annual Meeting via webcast at<I>
</I><U>https://www.webcaster4.com/Webcast/Page/2636/40168</U>. Alternatively, you may access the live Annual Meeting by dialing <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-407-8133</FONT></FONT> (U.S. &amp; Canada) or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">201-689-8040</FONT></FONT> (International). The webcast will begin at 12:00 p.m. Pacific time on May&nbsp;11, 2021. </P></TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Recommendation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors recommends
that you vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FOR each of the nominees for the Board of Directors, who are, John Bencich, Cindy Jacobs, Donald Joseph, Bridget
Martell, Martin Mattingly, Jay Moyes, and Richard Stewart; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FOR the ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the
fiscal year ending December&nbsp;31, 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All shares represented by a valid proxy received prior to the Annual Meeting will be voted, and, if you provide specific instructions, your shares will be
voted as you instruct. If you sign your proxy card with no further </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instructions and do not hold your shares beneficially through a broker, bank or other nominee, your shares will be voted FOR each of the nominees for the Board of Directors, FOR the ratification
of PwC as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021, and in the discretion of the proxy holders with respect to any other matters that properly come before the Annual Meeting or any
adjournment or postponement of the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How to Vote Your Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>YOUR VOTE IS IMPORTANT</B>. Your shares can be voted at the Annual Meeting only if you are represented by proxy, please take the time to vote your proxy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders of record, or &#147;registered stockholders,&#148; can vote by proxy in the following three ways: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="70%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>By Telephone:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Call the toll-free number indicated on the enclosed proxy card and follow the recorded instructions.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Via the Internet:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Go to the website indicated on the enclosed proxy card and follow the instructions provided.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>By Mail:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Mark your vote, date, sign and return the enclosed proxy card in the postage-paid return envelope provided.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held beneficially in &#147;street&#148; name through a nominee such as a financial institution, brokerage
firm, or other holder of record, your vote is controlled by that institution, firm or holder. Your vote by proxy may also be cast by telephone or via the Internet, as well as by mail, if your financial institution or brokerage firm offers such
voting alternatives. Please follow the specific instructions provided by your nominee on your voting instruction card. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note, that if your shares
are held beneficially through a bank, broker or other nominee and you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from the record holder. Should you wish to listen to the Annual Meeting, you can join at
<U>https://www.webcaster4.com/Webcast/Page/2636/40168</U>. Alternatively, you may access the live Annual Meeting by dialing <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-407-8133</FONT></FONT> (U.S. &amp; Canada) or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">201-689-8040</FONT></FONT> (International)<I><U>.</U></I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revocability of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may revoke or change any previously delivered proxy (including a proxy sent to you by someone other than us) at any time before the Annual Meeting by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering a written notice of revocation to our Secretary at our principal executive office at 1040 West Georgia
Street, Suite 1030, Vancouver, British Columbia, Canada V6E 4H1; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering a valid proxy bearing a later date or submitting a new later dated proxy. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you hold shares in street name through a broker, bank or other nominee, you must contact that bank, broker or other nominee to revoke any prior voting
instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you receive a proxy from someone other than us, see &#147;Stockholder Nominations&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quorum </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The presence, virtually or by proxy, of at least
a majority of the shares of common stock outstanding on the record date will constitute a quorum. Both abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are counted for the purpose of determining the presence of a quorum. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Votes Required to Approve Matters Presented at the Annual Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors are elected by a plurality of the votes properly cast at the Annual Meeting. Approval of Proposal Two requires a majority of the votes properly
cast at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For banks, brokers or other nominee accounts, they are entitled to vote shares held for a beneficial owner on &#147;routine&#148; matters without instructions
from the beneficial owner of those shares. For <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters, the beneficial owner of such shares is required to provide instructions to the bank, broker or other nominee in order for them to
be entitled to vote the shares held for the beneficial owner. Proposal One (election of our directors), will be treated as <FONT STYLE="white-space:nowrap">non-routine</FONT> matter. If you hold your shares in street name and you do not instruct
your bank, broker or other nominee how to vote in the election of directors, no votes will be cast on your behalf with respect to this proposal. The approval of Proposal Two (the ratification of the selection of PwC as our independent public
accounting firm), will be treated as a routine matter, and, therefore, no broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are expected to exist with respect to this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If you hold your shares in street name, it is critical that you cast your vote if you want it to count on all matters to be decided at the Annual Meeting.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Impact on the Vote of Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> and Abstentions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are counted for purposes of determining whether or not a quorum exists for the
transaction of business at the Annual Meeting. Broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> as well as abstentions from voting, will not, however, be treated as votes cast and, therefore, will have no effect on the outcome of Proposal
One (election of our directors) and Proposal Two (the ratification of the selection of PwC as our independent public accounting firm). As stated above, Proposal Two will be treated as a routine matter, which means that brokers will be able to use
their discretion to vote on behalf of the beneficial owner absent instructions from such owners; therefore, no broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are expected to exist with respect to this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Solicitation of Proxies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will bear the cost of
soliciting proxies, including preparing, assembling, printing and mailing this Proxy Statement, the proxy card and any additional information furnished to stockholders. Copies of solicitation materials will be furnished to banks, brokerage houses,
fiduciaries and custodians holding in their names shares of common stock beneficially owned by others to forward to such beneficial owners. We may reimburse persons representing beneficial owners of common stock for their costs of forwarding
solicitation materials to such beneficial owners. Original solicitation of proxies by mail may be supplemented by telephone, telegram, via the Internet or by personal solicitation by our directors, officers or other regular employees. No additional
compensation will be paid to these individuals for such services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Availability of Proxy Statement and Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Proxy Statement and Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year
ended December&nbsp;31, 2020 are available at www.sec.gov and on our website at ir.achievelifesciences.com. We have provided to each stockholder of record as of March&nbsp;15, 2021, a copy of our consolidated financial statements and related
information, which are included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for fiscal year 2020. We will mail without charge, upon written request, a copy of our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for fiscal year 2020, including the consolidated financial statements, schedules and list of exhibits, and any particular exhibit specifically requested. Requests should be sent to: Achieve Life Sciences,
Inc., 1040 West Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E 4H1, Attention: Investor Relations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_1"></A>BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected at each annual
stockholders meeting to hold office until the next annual meeting or until their successors are elected and have qualified. Currently, there are nine members of the Board of Directors. However, Scott Cormack and Stewart Parker will not be standing
for <FONT STYLE="white-space:nowrap">re-election</FONT> at the annual stockholders meeting, and therefore, effective as of the annual stockholders meeting, our Board of Directors will consist of seven members. The following table sets forth
information with respect to the directors nominated for election at the annual stockholders meeting. The ages of such persons are shown as of March&nbsp;15, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director&nbsp;Since</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Bencich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director and Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Stewart</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">62</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director, Executive Chairman and Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cindy Jacobs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">63</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director, President and Chief Medical Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Joseph</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director, Member of the Audit Committee, Compensation Committee and Nominating and Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Martin Mattingly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director, Chairperson of the Compensation Committee and Member of the Audit Committee and Nominating and Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2010</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Moyes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director, Chairperson of the Audit Committee and Member of the Nominating and Governance Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bridget Martell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2021</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors held a total of ten meetings during fiscal year 2020. During fiscal year 2020, each of our directors
attended at least 75% of the aggregate of: (i)&nbsp;the total number of meetings of the Board of Directors held during the period he or she was a director; and (ii)&nbsp;the total number of meetings held by all committees on which the director
served during the period he or she was a member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we do not have a formal policy regarding attendance by directors at annual meetings of
stockholders, we encourage directors to attend and, historically, most have done so. All of our directors then in office were in attendance at the 2020 annual meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to our Corporate Governance Guidelines, the Board of Directors is required to hold at least four regularly scheduled meetings each year. At least one
of these meetings must include budgeting and long-term strategic planning. Each director is expected to attend no fewer than 75% of the total of all meetings of the Board of Directors and meetings of the committees on which he or she serves. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are the names of, and information concerning, our current directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>John Bencich</I> has served as our Chief Executive Officer and member of the Board of Directors since September 2020. Previously, Mr.&nbsp;Bencich served
as our Vice President and Chief Financial Officer since August 2014 and as our Executive Vice President and Chief Operating Officer since August 2017. Mr.&nbsp;Bencich joined us from Integrated Diagnostics, Inc., a molecular diagnostics company,
where he served as Chief Financial Officer from September 2012 to August 2014. Prior to joining Integrated Diagnostics, he served as Chief Financial Officer of Allozyne, Inc. since July 2011. Mr.&nbsp;Bencich was an independent consultant from
November 2010 until he joined </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Allozyne. He served as the Vice President, Chief Financial Officer and Treasurer of Trubion Pharmaceuticals, Inc., a publicly traded biotechnology company, from November 2009 until its
acquisition by Emergent BioSolutions Inc. in October 2010. Mr.&nbsp;Bencich served as Trubion&#146;s Senior Director of Finance and Accounting from May 2007 through November 2009. From September 2004 to April 2007, Mr.&nbsp;Bencich was an employee
of Onyx Software Corporation, a publicly traded software company, where he last served as Director of Finance and Corporate Controller. From 1999 to 2004, Mr.&nbsp;Bencich was an employee of Ernst&nbsp;&amp; Young LLP, an international professional
services firm, where he last served as a manager. Mr.&nbsp;Bencich received a B.A. in Accountancy from the University of San Diego and an M.B.A. from Seattle University. Mr.&nbsp;Bencich received his Certified Public Accountant Certification from
the State of Washington and held an active license for 17 years. The determination was made that Mr.&nbsp;Bencich should serve on our Board of Directors based on our belief that the Board of Directors have the benefit of management&#146;s
perspective and, in particular, that of the Chief Executive Officer, as well as Mr.&nbsp;Bencich&#146;s extensive financial experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Richard
Stewart</I> has served as our Executive Chairman since September 2020 and our Chairman of the Board, and a director since the consummation of the Merger between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. in August 2017 (the
&#147;Merger&#148;). Previously, Mr.&nbsp;Stewart served as Chief Executive Officer from the Merger to September 2020, and was Chairman and a director of Achieve Life Science, Inc., from its founding in May 2015, through the Merger. Mr.&nbsp;Stewart
is also a founder and a director of Ricanto Limited, a pharmaceutical asset optimization company, since 2009. Mr.&nbsp;Stewart has been Chairman and Chief Executive Officer of Renown Pharma Limited, a central nervous system company focused on
Parkinson&#146;s disease, since 2016. Prior to Achieve, Mr.&nbsp;Stewart was Chairman and Chief Executive Officer of Huxley Pharmaceuticals, Inc., a single purpose central nervous system company, during 2009, prior to Huxley Pharmaceuticals,
Inc.&#146;s acquisition by BioMarin Pharmaceutical Inc. Mr.&nbsp;Stewart was Chief Executive Officer of Brabant Pharma Limited, a single purpose central nervous system company, from 2013 to 2014 prior to its acquisition by Zogenix Inc. He was a <FONT
STYLE="white-space:nowrap">co-founder</FONT> and Chief Executive Officer of Amarin Corporation plc, a central nervous system company focused on Parkinson&#146;s disease and Huntington&#146;s disease, from 2000 to 2007. Mr.&nbsp;Stewart was a <FONT
STYLE="white-space:nowrap">co-founder</FONT> and Chief Financial Officer, and later Chief Business Officer, of SkyePharma plc, a drug delivery company specializing in controlled release formulations, and held such positions from 1995 to 1998.
Mr.&nbsp;Stewart holds a Bachelor of Science degree in Business Administration from the University of Bath. The determination was made that Mr.&nbsp;Stewart should serve on our Board of Directors due to his prior service on boards of directors, and
extensive experience and innovations in the field of biotechnology. In addition, Mr.&nbsp;Stewart&#146;s accomplishments provide the Board of Directors with <FONT STYLE="white-space:nowrap">in-depth</FONT> product and field knowledge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cindy Jacobs</I>, Ph.D., M.D., has served as our President since September 2020 and our Chief Medical Officer since August 2008, and a member of the Board
of Directors since March 2021. Previously, Dr.&nbsp;Jacobs served as Executive Vice President and Chief Medical Officer of OncoGenex Pharmaceuticals, Inc. from September 2005 to August 2008. Dr.&nbsp;Jacobs is also the founder of Eagles Ridge
Executive Consulting LLC., an executive consulting business operating since July 2020. From 1999 to July 2005, Dr.&nbsp;Jacobs served as Chief Medical Officer and Senior Vice President, Clinical Development of Corixa Corporation. Prior to 1999,
Dr.&nbsp;Jacobs held Vice President, Clinical Research positions at two other biopharmaceutical companies. Dr.&nbsp;Jacobs has served on the Board of Directors of Renown Pharma Limited since January 2018 and Pacylex Pharmaceuticals Inc. since
October 2020. Dr.&nbsp;Jacobs received her Ph.D. degree in Veterinary Pathology/Microbiology from Washington State University and an M.D. degree from the University of Washington Medical School. The determination was made that Dr.&nbsp;Jacobs should
serve on our Board of Directors based on our belief that the Board of Directors have the benefit of management&#146;s perspective and, in particular, that of the President and Chief Medical Officer, as well as Dr.&nbsp;Jacob&#146;s extensive
clinical and regulatory experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Donald Joseph</I> has served as a director since August 2017. He currently serves as Chief Legal Officer and
Secretary of Acer Therapeutics Inc., a publicly listed pharmaceutical company, since April 2018. He previously served as an advisor and consultant to biopharmaceutical and global health organizations. He has over twenty years of biopharmaceutical
industry experience, including senior management positions in global health <FONT STYLE="white-space:nowrap">non-profit</FONT> organizations. Mr.&nbsp;Joseph served as the Chief Legal Officer and Board Secretary of Humanigen, Inc.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(previously known as KaloBios Pharmaceuticals, Inc.), a publicly listed company, from June 2013 to November 2015. Prior to Humanigen/KaloBios, he was Chief Executive Officer of BIO Ventures for
Global Health, or BVGH, from February to November 2012 and Chief Operating Officer from April 2010 to January 2012. He is a former Chairman and Secretary and director of BVGH. He previously served as general counsel, corporate secretary, and in
other senior management roles at publicly held biopharmaceutical companies, including Abgenix and Renovis. Before entering the life sciences industry, Mr.&nbsp;Joseph practiced business law for a number of years in major firms, including as an
international partner at Baker&nbsp;&amp; McKenzie, one of the world&#146;s largest law firms. He received his J.D. degree from the University of Texas School of Law, with honors.<I> </I>The determination was made that Mr.&nbsp;Joseph should serve
on our Board of Directors due to his experience as an executive officer and director of a number of companies in the life sciences industry, as well as his extensive legal experience. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Martin Mattingly</I>, Pharm.D., has served as a director since June 2010. Since December 2014, Dr.&nbsp;Mattingly has served as a director of TRACON
Pharmaceuticals, Inc. Previously, Dr.&nbsp;Mattingly served as the Chief Executive Officer of Trimeris, Inc., a biopharmaceutical company, from November 2007 until its merger with Synageva in November 2011. He also served on the Board of Directors
of Trimeris, Inc. from November 2007 until November 2011. From 2005 to 2007, Dr.&nbsp;Mattingly was employed at Ambrx, Inc., a biopharmaceutical company, where he served as President and Chief Executive Officer. From 2003 to 2005, Dr.&nbsp;Mattingly
served as Executive Vice President and Chief Operating Officer of CancerVax Corporation, a biotechnology company. From 1996 to 2003, he provided senior leadership in various management positions at Agouron Pharmaceuticals, Inc. and Pfizer, Inc.,
including serving as General Manager of the Agouron HIV division, Vice President, Product Development Group at Pfizer and Vice President, Global Marketing Planning at Pfizer. Dr.&nbsp;Mattingly holds a Pharm.D. degree from the University of
Kentucky. The determination was made that Dr.&nbsp;Mattingly should serve on the Board of Directors as a result of his executive leadership experience in late-stage clinical development, public company expertise, and commercialization and business
development experience with pharmaceuticals and biologics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Bridget Martell, M.A., M.D.,</I> has served as a director since March 2021.
Dr.&nbsp;Martell has served as Acting Chief Medical Officer of Nobias Therapeutics from August 2020 to present and for Verseau Therapeutics since December 2020. In October 2017, Dr.&nbsp;Martell began working with Kura Oncology, a clinical-stage
biopharmaceutical company, where she served as VP, Clinical Development from October 2017 to January 2020, as Acting Chief Medical Officer from January 2020 to August 2020 and as Senior Scientific Advisor since August 2020. Concurrently,
Dr.&nbsp;Martell served as Chief Medical Officer of RRD International, a boutique Contract Research Organization from April 2018 to January 2020. From January 2015 to September 2017, Dr.&nbsp;Martell served as Senior Vice President, New Product
Development at Juniper Pharmaceuticals, a publicly-held specialty pharmaceuticals company. From October 2011 to April 2013, she was Executive Director, Head Medical Affairs at Purdue Pharma L.P., a privately-held pharmaceutical company. Previous to
that, Dr.&nbsp;Martell held leadership roles of increasing responsibility at Pfizer, Inc., a publicly-held biopharmaceutical company from 2005 to 2011. Dr.&nbsp;Martell earned her B.S. in microbiology from Cornell University, her M.A. in molecular
immunology from Boston University and her M.D. from the Chicago Medical School. She completed her internship and residency in internal medicine and was an internal medicine chief resident and RWJ Faculty Clinical Scholar at Yale University.
Dr.&nbsp;Martell is board certified in both internal and addiction medicine. The determination was made that Dr.&nbsp;Martell should serve on the Board of Directors due to her diverse background of scientific, clinical and leadership experience in
the development and success of numerous marketed products across multiple therapeutic categories. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Jay Moyes</I> has served as a director since August
2017. Mr.&nbsp;Moyes has served on the Board of Directors of BioCardia, Inc. since 2011, and on the Board of Directors of Puma Biotechnology, Inc. since 2012. He also served as a member of the Board of Directors of Predictive Technology Group, Inc.
from February 2019 to December 2019, Osiris Therapeutics, Inc., from May 2006 to December 2017, and Integrated Diagnostics, a privately held molecular diagnostics company, from 2011 to 2016. Mr.&nbsp;Moyes served as a member of the Board
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Directors of Amedica Corporation, a publicly traded orthopedics company, and as their Chief Financial Officer from 2013 to 2014. Mr.&nbsp;Moyes also served as Chief Financial Officer of
CareDx, a publicly traded cardiovascular diagnostics company from 2008 to 2009. Prior to that, he served as Chief Financial Officer of Myriad Genetics, Inc., a publicly held molecular diagnostics company from 1993 until his retirement in November
2007. From 1991 to 1993, Mr.&nbsp;Moyes served as Vice President of Finance and Chief Financial Officer of Genmark, Inc., a privately held animal genetics company. Mr.&nbsp;Moyes held various positions with the accounting firm of KPMG from 1979 to
1991. He also served as a member of the Board of Trustees of the Utah Life Science Association from 1999 to 2006. Mr.&nbsp;Moyes holds a Masters of Business Administration from the University of Utah, a Bachelor of Arts in economics from Weber State
University, and was formerly a Certified Public Accountant. The determination was made that Mr.&nbsp;Moyes should serve on our Board of Directors due to his experience as a member of the boards of directors of a number of companies in the life
sciences industry, as well as his extensive finance and accounting experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Stewart, Mr.&nbsp;Joseph and Mr.&nbsp;Moyes were each appointed
to our Board of Directors upon consummation of the merger with OncoGenex Pharmaceuticals, Inc. on August&nbsp;1, 2017 pursuant to the Agreement and Plan of Merger and Reorganization, dated as of January&nbsp;5, 2017, by and among OncoGenex
Pharmaceuticals, Inc., Ash Acquisition Sub, Inc., Ash Acquisition Sub 2, Inc. and Achieve Life Science, Inc. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors has determined that Mr.&nbsp;Joseph, Dr.&nbsp;Martell, Dr.&nbsp;Mattingly and Mr.&nbsp;Moyes, are &#147;independent&#148; under the
applicable Securities and Exchange Commission, or the SEC, rules and the criteria established by<B> </B>The Nasdaq Stock Market LLC, or<B> </B>Nasdaq. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationships Among Directors, Executive Officers and Director Nominees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors, executive officers or director nominees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communication with the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders who are interested in communicating directly with members of the Board of Directors, or the Board of Directors as a group, may do so by writing
directly to the member(s) c/o Secretary, Achieve Life Sciences, Inc., 1040 West Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E 4H1. The Secretary will promptly forward to the Board of Directors or the individually named
directors all written communications received at the above address that the Secretary considers appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related-Party Transactions Policy and
Procedure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Audit Committee is responsible for reviewing and approving all related-party transactions and conflict of interest situations involving
a principal stockholder, a member of the Board of Directors or senior management. Our Code of Conduct and Business Ethics requires our executive officers and directors to report any conflicts of interest with our interests to our Audit Committee,
and generally prohibits our executive officers and directors from conflicts of interest with our interests. Waivers of our Code of Conduct and Business Ethics with respect to an executive officer or director may only be granted by the Board of
Directors or, if permitted by Nasdaq and any other applicable stock exchange&#146;s rules, our Nominating and Governance Committee. We do not have a specific policy concerning approval of transactions with stockholders who own more than five percent
of our outstanding shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as disclosed below and in &#147;Proposal One: Election of Directors&#148; from January&nbsp;1, 2020 to the present,
there have been no transactions, and there are currently no proposed transactions, in which the amount involved exceeds $120,000 to which we or any of our subsidiaries was or is to be a party and in which any director, director nominee, executive
officer, holder of more than 5% of our capital stock, or any immediate family member of any of these individuals, had or will have a direct or indirect material interest.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors&#146; Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors has established separately designated Audit, Compensation and Nominating and Governance Committees to assist it in performing its
responsibilities. The Board of Directors designates the members of these committees and the committee chairs annually, based on the recommendations of the Nominating and Governance Committee in consultation with the Chief Executive Officer and the
Chairperson of the Board of Directors. The Nominating and Governance Committee reviews committee assignments from time to time and considers the rotation of committee chairpersons and members with a view towards balancing the benefits derived from
the diversity of experience and viewpoints of the directors. The Board of Directors has adopted written charters for each of these committees, which are available on our website at ir.achievelifesciences.com under &#147;Corporate Governance.&#148;
The chairperson of each committee develops the agenda for that committee and determines the frequency and length of committee meetings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit
Committee and Audit Committee Financial Expert </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has been established in accordance with Section&nbsp;3(a)(58)(A) of the
Securities Exchange Act of 1934, as amended, or the Exchange Act, and is currently comprised of Jay Moyes (Chairperson), Donald Joseph, Martin Mattingly and Stewart Parker, each of whom the Board of Directors has determined satisfies the applicable
SEC and Nasdaq independence requirements for audit committee members. Ms.&nbsp;Parker is not standing for <FONT STYLE="white-space:nowrap">re-election</FONT> at the annual stockholders meeting, and therefore, will not serve on the Audit Committee
following the annual stockholders meeting. The Board of Directors has also determined that Mr.&nbsp;Moyes is an &#147;audit committee financial expert,&#148; as defined by the applicable rules of the SEC. The Audit Committee held four meetings
during fiscal year 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Audit Committee Responsibilities </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee is responsible for, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the independence, qualifications, services, fees and performance of our independent registered public
accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, replacing and discharging our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> the professional services provided by our independent
registered public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the scope of the annual audit and reports and recommendations submitted by our independent registered
public accounting firm; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our financial reporting and accounting policies, including any significant changes, with our management
and our independent registered public accounting firm. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please see the sections entitled &#147;Report of the Audit Committee&#148; and
&#147;Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm&#148; for further matters related to the Audit Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee
currently consists of Martin Mattingly (Chairperson), Donald Joseph and Stewart Parker, each of whom the Board of Directors has determined satisfies the applicable SEC and Nasdaq independence requirements. Ms.&nbsp;Parker is not standing for <FONT
STYLE="white-space:nowrap">re-election</FONT> at the annual stockholders meeting, and therefore, will not serve on the Compensation Committee following the annual stockholders meeting. In addition, each member of the Compensation Committee has been
determined to be a <FONT STYLE="white-space:nowrap">non-employee</FONT> director under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> as promulgated under the Exchange Act. The Compensation Committee reviews and recommends to the Board of
Directors the compensation for our executive officers and our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for their services as members of the Board of Directors. The Compensation Committee does not have any explicit authority to
delegate its duties. The Compensation Committee held five meetings during fiscal year 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2020, the Compensation Committee retained Radford, an Aon Hewitt company and a provider of compensation
market intelligence to the technology and life sciences industries, to provide a report summarizing relevant benchmark data relating to industry-appropriate peers and make recommendations regarding base salary, target total cash (base salary plus
target cash incentives), and terms of long-term equity incentive awards for our executives. No work performed by Radford during fiscal year 2020 raised a conflict of interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please see the sections entitled &#147;Executive Compensation&#148; and &#147;Director Compensation&#148; for further matters related to the Compensation
Committee and director and executive officer compensation matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee currently consists of Stewart Parker (Chairperson), Martin Mattingly, Jay Moyes and Donald Joseph, each of whom the
Board of Directors has determined satisfies the applicable SEC and Nasdaq independence requirements. Ms.&nbsp;Parker is not standing for <FONT STYLE="white-space:nowrap">re-election</FONT> at the annual stockholders meeting, and therefore, will not
serve on the Nominating and Governance Committee following the annual stockholders meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee reviews, evaluates
and proposes candidates for election to our Board of Directors, and considers any nominees properly recommended by stockholders. The Nominating and Governance Committee promotes the proper constitution of our Board of Directors in order to meet its
fiduciary obligations to our stockholders, and oversees the establishment of, and compliance with, appropriate governance standards. The Nominating and Governance Committee held four meetings during fiscal year 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors Leadership Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Stewart
has served as the Chairman of the Board since the Merger and our Executive Chairman since September 2020 and brings extensive executive leadership and experience with the development of our lead product candidate, cytisinicline. John Bencich has
served as Chief Executive Officer since September 2020. Mr.&nbsp;Bencich is an experienced financial executive with over 20 years guiding financial strategy in the life sciences and technology industries. Our Board of Directors believes that the
current Board leadership structure, coupled with a strong emphasis on Board independence and the role of the lead independent director, provides effective independent oversight of management. Independent directors and management sometimes have
different perspectives and roles in strategy development. Our independent directors bring experience, oversight and expertise from outside of our company. The Board also believes the current separation of the Chairman and Chief Executive Officer
roles allows the Chief Executive Officer to focus his time and energy on operating and managing the Company and leverages the Chairman&#146;s experience and perspective. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lead Independent Director </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Donald Joseph has served as
our lead independent director since August 2017, and provides an additional measure of balance, ensure the Board&#146;s independence and enhance its ability to fulfill its management oversight responsibilities. As lead independent director, among
other responsibilities, Mr.&nbsp;Joseph presides over regularly scheduled meetings at which only our independent directors are present, serves as a liaison between the Chief Executive Officer and the independent directors and performs such
additional duties as our Board of Directors may otherwise determine and delegate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors&#146; Role in Risk Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with our leadership structure, our management is charged with the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks that we face or may face and provides our Board of Directors with quarterly risk assessment and mitigation strategy updates, while our
Board of Directors and its committees are responsible for oversight of risk management. The Audit Committee has responsibility for oversight of financial reporting related risks, including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
those related to our accounting, auditing and financial reporting practices. In addition, the Audit Committee annually reviews and assesses the adequacy of our risk management policies and
procedures with regard to identifying our management of financial risks, reviews the quarterly updates on these risks that are received from management, and assesses the adequacy of management&#146;s implementation of appropriate systems to mitigate
and manage financial risks. Furthermore, under our Code of Business Conduct and Ethics, the Audit Committee is responsible for considering reports of conflicts of interest involving officers and directors. The Nominating and Governance Committee
oversees corporate governance risks, including implementing procedures to ensure that the Board of Directors operates independently of management and without conflicts of interest. In addition, the Nominating and Governance Committee oversees
compliance with our Code of Business Conduct and Ethics. The Compensation Committee oversees risks associated with our compensation policies, plans and practices. The Audit Committee, the Nominating and Governance Committee and the Compensation
Committee each report to the Board of Directors regarding the foregoing matters, and the Board of Directors approves any changes in corporate policies, including those pertaining to risk management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors has also adopted a Whistle Blowing Policy, which provides a means by which concerns about actual and suspected violations of our Code
of Business Conduct and Ethics and other public interest matters are to be reported. We recognize that individuals may not feel comfortable reporting a matter directly to the appropriate persons at the Company and therefore the Whistle Blowing
Policy provides a mechanism by which a person may report a matter to Nasdaq OMX Group Corporate Services, Inc., a third party retained by us. Under the policy, the Chairperson of the Audit Committee determines whether and, if so, how an
investigation is to be conducted and, together with the full Audit Committee in certain instances, resolves reported violations. In all cases, a report of the outcome is to be made to the Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Assessment of Compensation Programs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have
determined that our compensation policies, plans and practices are appropriately balanced and do not create risks that are reasonably likely to have a material adverse effect on our company. To make this determination, our management reviewed the
compensation policies, plans and practices for our executive officers, as well as for all other employees. We assessed the following features of our compensation, plans and practices: design, payment methodology, potential payment volatility,
relationship to our financial results, length of performance period, risk-mitigating features, performance measures and goals, oversight and controls, and plan features and values compared to market practices. Based on this review, we believe that
our compensation policies, plans and practices do not create risks that are reasonably likely to have a material adverse effect on our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No member of the Compensation Committee during fiscal year 2020 served as one of our officers, former officers or employees nor received directly or indirectly
compensation from the Company, other than in the capacity as a member of our Board and Compensation Committee. There was no direct or indirect control by the members of the Compensation Committee of the Company. No member of the Compensation
Committee, directly or indirectly, is the beneficial owner of more than 10% of the Company&#146;s equity, nor are they an executive officer, employee, director, general partner or a managing member of one or more entities that are together the
beneficial owners of more than 10% of the Company&#146;s equity. The Compensation Committee members are not aware of any business or personal relationship between (i)&nbsp;a member of the Compensation Committee and any person who has provided or is
providing advice to the Compensation Committee; and (ii)&nbsp;an executive officer of the Company and any firm or other person who is employed or is employing such person to provide advice to the Compensation Committee. During fiscal year 2020, none
of our executive officers served as a member of the compensation committee of any other entity, one of whose executive officers served as a member of our Board of Directors or Compensation Committee, and none of our executive officers served as a
member of the Board of Directors of any other entity, one of whose executive officers served as a member of our Compensation Committee. As of January 2018, Cindy Jacobs, our Chief Medical Officer, serves on the Board of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Directors of Renown Pharma Limited, of which Richard Stewart, our Executive Chairman and Chairman of the Board, and Anthony Clarke, our Chief Scientific Officer, are executive officers.
Dr.&nbsp;Jacobs does not receive any direct or indirect compensation for serving as a director of Renown. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Nomination Process </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director Qualifications </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of our Board of
Directors must have broad experience and business acumen, a record of professional accomplishment in his or her field, and demonstrate honesty and integrity consistent with our values. In evaluating director nominees, the Nominating and Governance
Committee considers a variety of factors, including, without limitation, the director nominee&#146;s skills, expertise and experience, wisdom, integrity, diversity, the ability to make independent analytical inquiries, the ability to understand our
business environment, the willingness to devote adequate time to Board of Directors&#146; duties, the interplay of the director nominee&#146;s experience and skills with those of other directors, and the extent to which the director nominee would be
a desirable addition to the Board of Directors and any committees of the Board of Directors. The Nominating and Governance Committee may also consider such other factors as it may deem are in the best interests of us and our stockholders.
Additionally, in accordance with the applicable securities laws and Nasdaq requirements, a majority of the members of the Board of Directors must be &#147;independent.&#148; We do not have a policy regarding diversity, but the Nominating and
Governance Committee does and will continue to consider each candidate&#146;s gender, racial, ethnic and sexual identity, experiences and qualities as described above and how these identities, experiences and qualities complement the diversity of
the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Identification of Nominees by the Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee identifies nominees by first determining the desired skills and experience of a new nominee based on the qualifications
discussed above. The Nominating and Governance Committee will solicit names for possible candidates from other directors, our senior level executives and individuals personally known to the directors, as well as third-party search firms. The
Nominating and Governance Committee evaluates all possible candidates, including individuals recommended by stockholders, using the same criteria. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Nominations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our bylaws contain
provisions that address the process by which a stockholder may nominate an individual to stand for election to the Board of Directors. The Nominating and Governance Committee will consider nominees properly recommended by stockholders. Stockholders
wishing to submit nominations must provide timely written notice to our Corporate Secretary containing the following information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name and address of the stockholder proposing such business, which we refer to as a Nominating Person;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the class and number of our shares that are owned beneficially by the Nominating Person; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">description of any agreement, arrangement or understanding with respect to Nominating Person and their respective
affiliates or associates and each director nominee proposed by the Nominating Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">description of any agreement, arrangement or understanding that has been entered into as of the date of the
notice by the Nominating Person, whether or not such instrument or right is subject to settlement in underlying shares of capital stock of ours, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for,
or increase or decrease the voting power of, the Nominating Person, with respect to securities of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Nominating Person is a holder of record of stock of ours entitled to vote at the Annual Meeting and intends
to appear in person or by proxy at the meeting to propose such nomination; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Nominating Person intends to deliver a proxy statement and/or form of proxy to holders of a sufficient number
of holders of our voting shares to elect such nominee or nominees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to each director nominee proposed by the Nominating Person, such nominee&#146;s written consent to
being named in our proxy statement as a nominee and to serving as a director, if elected; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such other information regarding the Nominating Person and each nominee proposed by the Nominating Person as
would be required to be disclosed in a proxy statement or other filings required to be made in connection with the solicitations or proxies for election of directors, or would be otherwise required, in each case pursuant to Regulation 14A under the
Exchange Act and the rules and regulations promulgated under the Exchange Act. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be timely, a Nominating Person&#146;s notice in
respect of a director nomination must be delivered to or mailed and received by our Corporate Secretary at our principal executive offices, Achieve Life Sciences, Inc., 1040 West Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E
4H1, not less than 90 nor more than 120 calendar days prior to the first anniversary of the previous year&#146;s annual meeting. In the event, however, that the date of the Annual Meeting is more than 30 days before or more than 60 days after the
anniversary date, notice must be delivered no more than 120 and not less than 90 days prior to the Annual Meeting or the close of business on the tenth day following the date which public disclosure of the date of such meeting is made. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Hedging and Pledging Prohibitions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of our Insider
Trading Policy, our employees (including our executive officers) and the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of directors are prohibited or require <FONT STYLE="white-space:nowrap">pre-clearance</FONT> approval
by our Compliance Officer from: (i)&nbsp;engaging in transactions involving options or other derivative securities on our securities, such as puts and calls, whether on an exchange or in any other market; (ii)&nbsp;engaging in hedging or
monetization transactions involving our securities, such as <FONT STYLE="white-space:nowrap">zero-cost</FONT> collars and forward sale contracts; (iii)&nbsp;engaging in short sales of our securities, including short sales &#147;against the
box&#148;; and (iv)&nbsp;using or pledging our securities as collateral in a margin account or as collateral for a loan unless the pledge has been approved by our Compliance Officer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Ethics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that sound corporate
governance policies are essential to earning and retaining the trust of investors. We are committed to maintaining the highest standards of integrity. We have adopted a Code of Business Conduct and Ethics that is applicable to our principal
executive officer, our principal financial officer and our principal accounting officer, as well as to all of our other employees and directors, and have posted such code on our website at ir.achievelifesciences.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_2"></A>PROPOSAL ONE: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominees
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following persons are our 2021 director nominees, each of whom was recommended by the Nominating and Governance Committee and approved by the
Board of Directors for nomination at the Annual Meeting: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">John Bencich </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cindy Jacobs </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Donald Joseph </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Bridget Martell </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Martin Mattingly </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jay Moyes </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Richard Stewart </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise instructed, the proxy holders will vote the proxies received by them for the nominees named above. If a nominee is unable to serve or for
good cause will not serve as a director at the time of the Annual Meeting, the proxies will be voted for any nominee who is designated by the present Board of Directors to fill the vacancy. Each nominee has consented to being named in this Proxy
Statement and to serve if elected. We do not expect that any nominee will be unable to serve or for good cause will not serve as a director. Each director is elected annually to serve until the next annual meeting of stockholders or until a
successor has been duly elected and has qualified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biographies of our 2021 director nominees are located above under the heading &#147;Board of Directors
&#150; General.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The charter of the Compensation Committee provides that the Compensation Committee is to recommend to the Board of Directors matters related to director
compensation. The director compensation package for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors consists of annual cash compensation and stock options exercisable to purchase shares of our common stock. None of our employees who
also serve as directors are entitled to receive compensation for service as a director. Therefore, Richard Stewart, John Bencich and Cindy Jacobs receive no compensation for their service as a director. Our director compensation policy for fiscal
year 2020 is set forth below under the heading &#147;Director Compensation Policy &#150; 2020 Director Compensation.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation
Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2020 Director Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of its
evaluation of compensation levels for the 2020 fiscal year, the Compensation Committee recommended, and the Board of Directors approved the retention of Radford to review compensation levels of our independent directors and committee members.
Radford was instructed to benchmark and make recommendations regarding the initial and annual retainer amounts for directors and chairpersons of the Board of Directors and the various committees, as well as the amounts and terms of initial and
annual long-term equity incentive awards for directors. On recommendation by Radford in 2020, the equity compensation and cash compensation for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in connection with their service on the
Board of Directors remains unchanged and is as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">An annual retainer of $60,000 was paid to the Lead Independent Director and $40,000 was paid to all other <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. These retainers were paid in quarterly installments. Each quarterly </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
payment was conditioned on the director remaining a director on the date of actual payment, which was typically within 10 days following the completion of the respective calendar quarter.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Additional annual cash compensation for the chairpersons and members of each committee as set forth in the
following table and paid on the same schedule and on the same terms as the <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation described above: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Chairperson</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Other&nbsp;Members</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any new director would have received a <FONT STYLE="white-space:nowrap">one-time</FONT> initial grant of stock
options to acquire 5,650 shares of our common stock upon becoming a director, which would vest monthly over three years from the date of grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each director that was <FONT STYLE="white-space:nowrap">re-elected</FONT> by our stockholders at an annual
meeting was to receive a grant of stock options to acquire 7,000 shares of common stock. However, in May 2020, the Compensation Committee and Board determined to grant 22,000 stock options based upon the recommendation by Radford after an evaluation
of the recent market data and changes in the Company&#146;s capital structure. Each annual stock option vests in full on the earlier of the first anniversary of the date of grant or the date immediately prior to our next annual meeting of
stockholders. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Compensation Paid for 2020 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes all compensation paid to or earned by <FONT STYLE="white-space:nowrap">non-employee</FONT> directors who served during 2020 as
compensation for board service during the 2020 fiscal year. Drs. Martell and Jacobs were appointed to our Board of Directors in March 2021 and are not included in the table below as they did not serve as a director in 2020. Anthony Clarke, our Chief
Scientific Officer, as served as a director until September 2020 but received no compensation for his service as a director. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(1)&nbsp;(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Cormack<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Joseph</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Martin Mattingly</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Moyes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stewart Parker<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The dollar amounts reflect the aggregate grant date fair value of equity awards granted within the fiscal year
in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 718 for stock-based compensation. These amounts do not correspond to the actual cash value that will be recognized by the directors when
received. Assumptions used in the calculation of the amounts in this column are included in note 10 to our audited consolidated financial statements included in our 2020 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> As of
December&nbsp;31, 2020, the following directors had the following number of options outstanding: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Scott Cormack: 2,195 options, of which 1,095 were vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Donald Joseph: 2,132 options, of which 1,032 were vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Martin Mattingly: 2,123 options, of which 1,023 were vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jay Moyes: 2,132 options, of which 1,032 were vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stewart Parker: 2,123 options, of which 1,023 were vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These options were granted on May&nbsp;12, 2020 under our 2018 Equity Incentive Plan and vest 100% on
May&nbsp;10, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Cormack and Ms.&nbsp;Stewart are not standing for <FONT STYLE="white-space:nowrap">re-election</FONT>
at our annual stockholders meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE ELECTION OF ALL
OF THE NOMINEES. </B></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_3"></A>REPORT OF THE AUDIT COMMITTEE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the consolidated financial statements for the fiscal year ended December&nbsp;31, 2020, the Audit Committee has: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed and discussed the audited consolidated financial statements with management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>discussed with PwC, our independent registered public accounting firm, the matters required to be
discussed by Auditing Standard No.&nbsp;16 adopted by the Public Company Accounting Oversight Board (United States) regarding &#147;<I>Communication with Audit Committees</I>&#148;; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>received the written disclosures and letter from PwC required by applicable requirements of the Public
Company Accounting Oversight Board regarding the independent registered public accounting firm&#146;s communications with the audit committee concerning independence, and has discussed with PwC its independence from us. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the Audit Committee&#146;s review of the audited consolidated financial statements and its discussions with management and PwC, the Audit Committee
recommended to the Board of Directors that the audited consolidated financial statements for the 2020 fiscal year be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the SEC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:45%; font-size:10pt; font-family:Times New Roman">AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:45%; font-size:10pt; font-family:Times New Roman">Jay Moyes, Chairperson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:45%; font-size:10pt; font-family:Times New Roman">Donald
Joseph </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:45%; font-size:10pt; font-family:Times New Roman">Martin Mattingly Stewart Parker </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The information contained in the report above shall not be deemed to be &#147;soliciting material&#148; or to be &#147;filed&#148; with the SEC, nor
shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference in such filing. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL TWO: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_4"></A>RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed PricewaterhouseCoopers LLP, or PwC, as our independent registered public accounting firm for the fiscal year ending
December&nbsp;31, 2021. PwC audited our financial statements for the fiscal years ended December&nbsp;31, 2020 and 2019. A representative of PwC will be present at the Annual Meeting, will be given the opportunity to make a statement, if he or she
desires, and will be available to respond to appropriate questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proxies solicited by management for which no specific direction is included will be
voted &#147;FOR&#148; the ratification of the appointment of PwC as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fees Billed by Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the fees billed by PwC for the fiscal years ended December&nbsp;31, 2020 and December&nbsp;31, 2019: Amounts are presented in
USD. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Fee Category</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Fiscal&nbsp;2020&nbsp;PwC&nbsp;Fees<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Fiscal&nbsp;2019&nbsp;PwC&nbsp;Fees<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">145,692</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">137,350</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">136,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">103,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,142</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,455</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Fees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>297,273</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>247,053</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Accountant fees and services charged by PwC are paid in Canadian dollars and shown in USD. For fiscal 2020, the
fees were CDN$398,792 and was converted at an average exchange rate of US$1.00=CDN$1.3415. For fiscal 2019, the fees were CDN$327,815 and was converted at an average exchange rate of US$1.00=CDN$1.3269. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Audit Fees for fiscal 2020 and fiscal 2019 are fees billed and to be billed for the audit of our consolidated
financial statements, review of the consolidated financial statements included in our quarterly reports, and for services in connection with regulatory filings and engagements. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tax fees billed by PwC relate to tax consulting services provided by PwC to Achieve Life Sciences, Inc. in
fiscal 2019 and 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Fees</I></B>. Consists of fees billed for professional services rendered for the audit of our
consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> that are filed with the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit-Related Fees</I></B>. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or
review of our consolidated financial statements, including accounting consultations and fees related to registration of securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy on Audit
Committee <FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of Audit Services and Permissible <FONT STYLE="white-space:nowrap">Non-Audit</FONT> Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee&#146;s policy is to <FONT STYLE="white-space:nowrap">pre-approve</FONT> all audit and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services performed by our independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. For audit services, our
independent registered public accounting firm typically provides audit service detail in advance of the second quarter meeting of the Audit Committee, which outlines the scope of the audit and related audit fees. If agreed to by the Audit Committee,
an engagement letter is formally accepted by the Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For <FONT STYLE="white-space:nowrap">non-audit</FONT> services, our senior management will submit from time
to time to the Audit Committee for approval <FONT STYLE="white-space:nowrap">non-audit</FONT> services that it recommends the Audit Committee engage our independent registered public accounting firm to provide for the fiscal year. Our senior
management and our independent registered public accounting firm will each confirm to the Audit Committee that each <FONT STYLE="white-space:nowrap">non-audit</FONT> service is permissible under all applicable legal requirements. A budget,
estimating <FONT STYLE="white-space:nowrap">non-audit</FONT> service spending for the fiscal year, will be provided to the Audit Committee along with the request. The Audit Committee must approve both permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services and the budget for such services. The Audit Committee will be informed routinely as to the <FONT STYLE="white-space:nowrap">non-audit</FONT> services actually provided by our independent
registered public accounting firm pursuant to this <FONT STYLE="white-space:nowrap">pre-approval</FONT> process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the 2019 and 2020 fiscal years, the
Audit Committee approved all of the services provided by PwC described above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE RATIFICATION OF
THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER&nbsp;31, 2021. </B></P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_5"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding our current executive officers as of March&nbsp;15, 2021. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Position With the Company</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Bencich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Stewart</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Chairman</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cindy Jacobs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anthony Clarke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Scientific Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry Wan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Principal Accounting Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following are the biographies of the foregoing persons, except the biographies of Mr.&nbsp;Bencich, Mr.&nbsp;Stewart and
Dr.&nbsp;Jacobs, which are located above under the heading &#147;Board of Directors&#151;General.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anthony Clarke</I> has served as our Chief
Scientific Officer since August 2017. Previously, Dr.&nbsp;Clarke served as our President and director from August 2017 to September 2020. Prior to the Merger, Dr.&nbsp;Clarke served as Achieve Life Science, Inc.&#146;s Chief Scientific Officer and
as a member of Achieve Life Science, Inc.&#146;s Board of Directors since 2015. Dr.&nbsp;Clarke is a founder and director of Ricanto Limited since 2009. From 2016 to the present, Dr.&nbsp;Clarke has been Chief Scientific Officer of Renown Pharma
Limited. Dr.&nbsp;Clarke was Chief Scientific Officer of Huxley Pharmaceuticals, Inc. during 2009, prior to Huxley Pharmaceuticals, Inc.&#146;s acquisition by BioMarin Pharmaceutical Inc. Prior to Achieve, Dr.&nbsp;Clarke served as Chief Scientific
Officer of Brabant Pharma Limited from 2013 to 2014 prior its acquisition by Zogenix Inc. Dr.&nbsp;Clarke served as Company Secretary of Alexza UK Ltd. and as Vice President International Development Operations of Alexza Pharmaceuticals Inc., a
pharmaceutical development company, holding both positions from 2008 to 2009. Dr.&nbsp;Clarke served as the Vice President, Clinical Research and Regulatory Affairs at Amarin Corporation from 2005 to 2008. In addition, Dr.&nbsp;Clarke was Senior
Director, Clinical and Regulatory Affairs, of Cephalon Europe and as Senior Director, Worldwide Pain Management, of Cephalon, Inc. from 2000 to 2004. Dr.&nbsp;Clarke held a number of management roles in other pharmaceutical companies prior to 2000
as well as academic posts and honorary academic posts. Dr.&nbsp;Clarke holds a Bachelor&#146;s degree in Pharmacology from the University of Sunderland and a Ph.D. in psychopharmacology from the University of London. He was a Fellow of the Royal
Statistical Society (UK) and is a current Fellow of the Royal Society of Medicine (UK). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Jerry Wan</I> has served as our Principal Accounting Officer
since September 2020 and served as our Senior Director, Accounting Operations since June 2018. He previously served as our Director, Accounting Operations from August 2017 to June 2018 and as the Director, Accounting Operations of OncoGenex
Pharmaceuticals, Inc. (&#147;OncoGenex&#148;) from July 2014 to August 2017. From July 2012 to July 2014, Mr.&nbsp;Wan served as OncoGenex&#146;s Senior Manager, Finance and Accounting and, from October 2011 to July 2012, as its Manager, Financial
Reporting and Analysis. Prior to joining OncoGenex, Mr.&nbsp;Wan served as Manager, Management Reporting at Gateway Casinos and Entertainment Limited from 2010 to 2011. From 2006 to 2010, Mr.&nbsp;Wan was an employee of PricewaterhouseCoopers LLP,
an international professional services firm, where he last served as Manager, Audit and Assurance Group. Mr.&nbsp;Wan received his Bachelor of Commerce in Accounting from The University of British Columbia and a Chartered Accountant Designation from
the Canadian Institute of Chartered Accountants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_6"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the 2020 fiscal year, our Named Executive Officers and their respective positions were as follows: John Bencich, Chief Executive Officer and former
Chief Financial Officer and Chief Operating Officer; Richard Stewart, Executive Chairman and former Chief Executive Officer; and Cindy Jacobs, Ph.D., M.D., President and Chief Medical Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Bencich, Dr.&nbsp;Jacobs and Mr.&nbsp;Stewart are referred to as our Named Executive Officers for purposes of this Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SEC rules require that this discussion regarding 2020 executive officer compensation cover executive officers that served during 2020. We note that
Mr.&nbsp;Stewart resigned from his position as Chief Executive Officer on September&nbsp;28, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation of our Named Executive Officers for each of the fiscal years ended December&nbsp;31,
2020, 2019 and 2018. The components of the compensation reported in the Summary Compensation Table are described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name and Principal Position</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Salary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option<BR>Awards</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($)(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Plan</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Compensation<BR>($)(2)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Bencich,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,914&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">199,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883,732</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer and</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Former Chief Financial Officer and</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">694,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Stewart,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">473,846&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Chairman and</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Former Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">796,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,090,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cindy Jacobs,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,231&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">194,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">773,902</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Medical Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">712,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The dollar amounts in this column reflect the aggregate grant date fair value of equity awards granted during
the fiscal year in accordance with FASB Accounting Standards Codification Topic 718 for stock-based compensation. These amounts do not correspond to the actual cash value that will be recognized by each of the Named Executive Officers when received.
For a discussion of the assumptions and methodologies used to value the awards reported in this column, see note 10 to our audited consolidated financial statements, which are included in our 2020 Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K.</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The dollar amounts in this column reflect the aggregate <FONT STYLE="white-space:nowrap">non-equity</FONT>
incentive plan compensation earned by each Named Executive Officer in 2020. For more information, see &#147;&#151;2020 Bonuses&#148; below. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Bencich was appointed as Chief Executive Officer and resigned as Chief Financial Officer and Chief
Operating Officer as of September&nbsp;28, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Stewart resigned as our Chief Executive Officer and appointed Executive Chairman of the Board as of
September&nbsp;28, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Jacobs was appointed President as of September&nbsp;28, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Equity Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equity awards are granted to
executive officers at the discretion of the Compensation Committee. In January 2020, the Compensation Committee granted 10,000 options to purchase common stock to each of John Bencich </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Cindy Jacobs and 22,500 to Richard Stewart. The stock options have an exercise price of $11.20 and vest as to 25% on January&nbsp;28, 2021 and thereafter vest in equal monthly installments
over 36 months. In November 2020, the Compensation Committee also granted 12,000 options to purchase common stock to Cindy Jacobs, 15,000 to Richard Stewart and 20,000 to John Bencich. The stock options have an exercise price of $10.36 and vest as
to 50% of the total options on the achievement of the positive Phase 3 <FONT STYLE="white-space:nowrap">ORCA-2</FONT> data results and thereafter 50% vest on the first anniversary of the achievement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Bonuses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Annual bonuses for our executive
officers are based on the achievement of corporate performance objectives, which in 2020 included the achievement of clinical development and financial milestones. In January 2021, our compensation committee determined that approximately 95% of our
2020 corporate performance objectives were achieved and determined that 95% of each executive officer&#146;s target bonus should be awarded based on the initiation of the Phase 3 <FONT STYLE="white-space:nowrap">ORCA-2</FONT> clinical trial,
submission of chronic toxicology studies, and completion of financings to ensure sufficient working capital into 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to the payment of
these bonuses, John Bencich&#146;s target bonus was equal to 50% of his annual base salary of $465,000 and he was awarded $199,610, Richard Stewart&#146;s target bonus was equal to 50% of his annual base salary of $400,000 and he was awarded
$225,630, and Cindy Jacob&#146;s target bonus was equal to 40% of her annual base salary of $440,000 and she was awarded $159,580. The bonus amounts received were calculated on a <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis based on
earnings during the year as the annual base salary for each was increased in October 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the outstanding equity awards held by the Named
Executive Officers as of December&nbsp;31, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>STOCK AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7.5pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)&nbsp;Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)&nbsp;Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares or<BR>Units or<BR>Other&nbsp;Rights<BR>that Have<BR>Not&nbsp;Vested(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value of<BR>Shares or<BR>Units or<BR>Other&nbsp;Rights<BR>that Have<BR>Not&nbsp;Vested</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Richard Stewart,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/26/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ROWSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Chairman and</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Former Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/20/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/28/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cindy Jacobs,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,600.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/08/22&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ROWSPAN="11"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive Vice</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">President and</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Chief Medical</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,290.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/12/23&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,938.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/14/24&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,092.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/19/25&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">578.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/01/27&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(11)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/26/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/20/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/28/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(12)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>STOCK AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7.5pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)&nbsp;Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)&nbsp;Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares or<BR>Units or<BR>Other&nbsp;Rights<BR>that Have<BR>Not&nbsp;Vested(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value of<BR>Shares or<BR>Units or<BR>Other&nbsp;Rights<BR>that Have<BR>Not&nbsp;Vested</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John Becich,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,974.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/12/24&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ROWSPAN="9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive Vice</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">President, Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">and Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,092.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/19/25&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">578.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/01/27&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(11)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/26/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/20/28&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/29/29&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/28/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/30&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">(12)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2017 Equity Incentive Plan and vest monthly over a <FONT
STYLE="white-space:nowrap">48-month</FONT> period beginning July&nbsp;26, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2018 Equity Incentive Plan and vest monthly over a <FONT
STYLE="white-space:nowrap">48-month</FONT> period beginning September&nbsp;20, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2018 Equity Incentive Plan and vest as to 25% on January&nbsp;29,
2020 and then monthly over a <FONT STYLE="white-space:nowrap">36-month</FONT> period. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2018 Equity Incentive Plan and vested as to 25% on June&nbsp;12,
2019 on the achievement of the positive Phase 2 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ACH-CYT-09</FONT></FONT> data results and thereafter vest in monthly installments over 24 months. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2018 Equity Incentive Plan and vest as to 25% on January&nbsp;28,
2021 and then monthly over a <FONT STYLE="white-space:nowrap">36-month</FONT> period. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2018 Equity Incentive Plan and vest as to 50% on the achievement of
the positive Phase 3 <FONT STYLE="white-space:nowrap">ORCA-2</FONT> data results and thereafter 50% on the first anniversary of the achievement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on
December&nbsp;31, 2016. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on
December&nbsp;31, 2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on
January&nbsp;1, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on
January&nbsp;1, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2017 Equity Incentive Plan and vested as to 25% on August&nbsp;1,
2018 and then monthly over a <FONT STYLE="white-space:nowrap">36-month</FONT> period. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These RSUs were granted under the 2010 Performance Incentive Plan and vest annually over four years beginning
August&nbsp;1, 2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on
August&nbsp;12, 2018. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments Upon Termination/Change of Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change of Control Under Our Equity Compensation Plans </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion sets forth the change of control provisions provided for in our various equity compensation plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2010 Performance Incentive Plan </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2010 Plan, the administrator has the discretion to provide in each award agreement the terms and conditions with respect to a change of control that
relate to the vesting of an award and the assumption of an award or issuance of comparable securities under an incentive program. If the terms of an option agreement provide for accelerated vesting in the event of a change of control, or to the
extent that an option is vested and not yet exercised, the administrator may provide for the purchase or exchange of each option for an amount of cash or other property. Outstanding options shall terminate and cease to be exercisable upon a change
of control except to the extent that the options are assumed by the successor entity (or parent of the successor entity) pursuant to the terms of the change of control transaction. As used in the 2010 Plan, the term &#147;change of control&#148;
means the occurrence of any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquisitions of our securities possessing more than 50% of the total combined voting power of all of our
outstanding securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a merger or consolidation with any other entity, whether or not we are the surviving entity in such transaction,
except for a transaction in which the holders of our outstanding voting securities immediately prior to such merger or consolidation hold, as a result of holding our securities prior to such transaction, in the aggregate, securities possessing more
than 50% of the total combined voting power of all of our outstanding voting securities or the voting securities of the surviving entity, or the parent of the surviving entity, immediately after such merger or consolidation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sale, transfer or other disposition, in one transaction or a series of related transactions, of all or
substantially all of our assets; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the approval by the stockholders of a plan or proposal for our liquidation or dissolution. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2017 Equity Incentive Plan </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2017 Equity
Incentive Plan, or the 2017 Plan, unless otherwise determined by the compensation committee, all outstanding awards will be subject to the agreement governing such merger, asset sale or other change of control transaction. Such agreement need not
treat all such awards in an identical manner, and it will provide for one or more of the following with respect to each award: the continuation of the award, the assumption of the award, the substitution of the award, the full or partial
acceleration of the award, the settlement of the award in cash, equivalents or securities of the successor entity (or its parent, if any) or the cancellation of the award in exchange for no consideration. In the event the successor corporation
refuses to either assume, convert, replace or substitute awards, then the compensation committee will notify the award holder in writing or electronically that such award will be exercisable for a period of time determined by the compensation
committee (in its sole discretion) and that the award will terminate upon expiration of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in the event of a Corporate
Transaction, the vesting of all awards granted to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors shall accelerate and such awards shall become exercisable (as applicable) in full as of the time of consummation of such change in
control transaction. As used in the 2017 Plan, the term &#147;corporate transaction&#148; means the occurrence of any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the
&#147;beneficial owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act), directly or indirectly, of our securities representing more than 50% of the total voting power represented by our then-outstanding
voting securities; provided, however, that for purposes of this subclause (a)&nbsp;the acquisition of additional securities by any one Person who is considered to own more than 50% of the total voting power of our securities will not be considered a
Corporate Transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consummation of the sale or disposition by us of all or substantially all of our assets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consummation of a merger or consolidation of our Company with any other corporation, other than a merger or
consolidation which would result in our voting securities outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
securities of the surviving entity or its parent) at least 50% of the total voting power represented by our voting securities or such surviving entity or our parent outstanding immediately after
such merger or consolidation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other transaction which qualifies as a &#147;corporate transaction&#148; under Section&nbsp;424(a) of
Internal Revenue Code of 1986, as amended, or the Code, wherein our stockholders give up all of their equity interest in us (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of our capital stock); or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a change in the effective control of our Company that occurs on the date that a majority of members of the Board
of Directors is replaced during any 12 month period by members of the Board of Directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors prior to the date of the appointment or
election.</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2018 Equity Incentive Plan </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a Corporate Transaction, unless otherwise determined by the compensation committee, all outstanding awards will be subject to the agreement
governing such merger, asset sale or other change of control transaction. Such agreement need not treat all such awards in an identical manner, and it will provide for one or more of the following with respect to each award: the continuation of the
award, the assumption of the award, the substitution of the award, the full or partial acceleration of the award, the settlement of the award in cash, equivalents or securities of the successor entity (or its parent, if any) or the cancellation of
the award in exchange for no consideration. In the event the successor corporation refuses to either assume, convert, replace or substitute awards, then the compensation committee will notify the award holder in writing or electronically that such
award will be exercisable for a period of time determined by the compensation committee (in its sole discretion) and that the award will terminate upon expiration of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in the event of a Corporate Transaction, the vesting of all awards granted to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors
shall accelerate and such awards shall become exercisable (as applicable) in full as of the time of consummation of such change in control transaction. &#147;Corporate Transaction&#148; means the occurrence of any of the following events: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the
&#147;beneficial owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act), directly or indirectly, of our securities representing more than 50% of the total voting power represented by our then-outstanding
voting securities; provided, however, that for purposes of this subclause (a)&nbsp;the acquisition of additional securities by any one Person who is considered to own more than 50% of the total voting power of our securities will not be considered a
Corporate Transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consummation of the sale or disposition by us of all or substantially all of our assets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consummation of a merger or consolidation of our Company with any other corporation, other than a merger or
consolidation which would result in our voting securities outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least 50%
of the total voting power represented by our voting securities or such surviving entity or our parent outstanding immediately after such merger or consolidation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other transaction which qualifies as a &#147;corporate transaction&#148; under Section&nbsp;424(a) of the
Code wherein our stockholders give up all of their equity interest in us (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of our capital stock); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a change in the effective control of our Company that occurs on the date that a majority of members of the Board
of Directors is replaced during any 12 month period by members of the Board of Directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors prior to the date of the appointment or election.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination and Change of Control Provisions Under Employment Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had employment agreements in place with each of our Named Executive Officers<B> </B>that provided for compensation upon the
termination of their employment under certain circumstances, as described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Stewart Agreement </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our agreement with Richard Stewart, referred to as the Stewart Agreement, provides Mr.&nbsp;Stewart with termination benefits in the event of an involuntary
termination, provided that, in the case of termination for good reason, Mr.&nbsp;Stewart has provided us within 60&nbsp;days of becoming aware of conditions giving rise to a good reason written notice and an opportunity to cure such breach within 30
days of being served the notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Stewart Agreement provides that if an Involuntary Termination occurs, we will be obligated to pay Mr.&nbsp;Stewart a
lump sum payment equal to 18&nbsp;months of his then-current base salary and continue paying his monthly health insurance premiums for a discretionary period to be decided by us. Notwithstanding the terms of any of our equity compensation plans or
any agreement in connection with such plans, if there is an Involuntary Termination, then the time-based vesting restrictions, if any, will immediately lapse on an additional number of shares under all of Mr.&nbsp;Stewart&#146;s outstanding
compensatory equity awards, which includes outstanding stock options granted to Mr.&nbsp;Stewart under our equity compensation plans, that would have time-vested if Mr.&nbsp;Stewart had continued in employment for 18&nbsp;months following his
Involuntary Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Stewart Agreement provides for additional termination benefits for any reason other than cause (as defined in the employment
agreement) or if he voluntarily resigns for good reason (as defined in the employment agreement) within 12 months after a change of control of the Company. Upon such a Change in Control Termination, we will be obligated to pay Mr.&nbsp;Stewart a sum
equal to his average monthly salary over the immediately preceding 24&nbsp;months multiplied by 24, plus a sum equal to 100% of his target annual bonus for the year during which the termination occurs. In addition, we will be obligated to continue
payment of his health insurance premiums for a discretionary period to be decided by us, subject to certain limitations. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, upon a Change
in Control Termination, all vesting restrictions, if any, including awards that would otherwise vest only upon satisfaction of performance criteria, will immediately lapse on all of Mr.&nbsp;Stewart&#146;s compensatory equity effective as of his
separation from service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All termination benefits in the event of an involuntary termination or change in control termination are subject to
Mr.&nbsp;Stewart&#146;s execution, delivery and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a general release of all litigation and other claims against us and our affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Jacobs Agreement </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our agreement with Cindy Jacobs,
referred to as the Jacobs Agreement, provides Dr.&nbsp;Jacobs with termination benefits in the event of an Involuntary Termination, provided that, in the case of termination for good reason, Dr.&nbsp;Jacobs has provided us with 30&nbsp;days&#146;
advance written notice and an opportunity to cure such breach during such <FONT STYLE="white-space:nowrap">30-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Jacobs Agreement
provides that if an Involuntary Termination occurs, we will be obligated to pay Dr.&nbsp;Jacobs a lump sum payment equal to 12&nbsp;months of her then-current base salary. In addition, if Dr.&nbsp;Jacobs elects to continue her and her
dependents&#146; health insurance coverage under COBRA, we must pay up to 12&nbsp;months of Dr.&nbsp;Jacobs&#146; monthly premium under COBRA, provided that our obligation to pay the monthly premium will cease when Dr.&nbsp;Jacobs becomes eligible
to receive substantially equivalent health coverage in connection with new employment. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, if there is an Involuntary Termination, then the
time-based vesting restrictions, if any, will immediately lapse on an additional number of shares under all of Dr.&nbsp;Jacobs&#146; outstanding compensatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equity awards, which includes outstanding stock options granted to Dr.&nbsp;Jacobs under our equity compensation plans, that would have time-vested if Dr.&nbsp;Jacobs had continued in employment
for 12&nbsp;months following her Involuntary Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Jacobs Agreement provides for additional termination benefits if an Involuntary Termination
occurs during the period beginning three months before and ending 12&nbsp;months after a change in control or if such Involuntary Termination is required by the merger agreement, purchase agreement or other instrument relating to such change in
control, or such Involuntary Termination is made at the express request of the other party or parties to the transaction constituting such change in control, each of which events is referred to as a Change in Control Termination. Upon such a Change
in Control Termination, we will be obligated to pay Dr.&nbsp;Jacobs 15&nbsp;months of her then-current base salary, plus a sum equal to 12&nbsp;months of her average monthly bonus earnings, where such average is calculated over the <FONT
STYLE="white-space:nowrap">24-month</FONT> period immediately preceding Dr.&nbsp;Jacobs&#146; separation from services and based on Dr.&nbsp;Jacobs&#146; bonuses paid in such <FONT STYLE="white-space:nowrap">24-month</FONT> period. In addition, our
payment of monthly COBRA premiums as described above will be for up to 15&nbsp;months instead of up to 12&nbsp;months. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, upon a Change in
Control Termination, all vesting restrictions, if any, will immediately lapse on all of Dr.&nbsp;Jacobs&#146; compensatory equity effective as of her separation from service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All termination benefits in the event of an Involuntary Termination or Change in Control Termination are subject to Dr.&nbsp;Jacobs&#146; execution, delivery
and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a general release of all litigation and other claims against us and our affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Bencich Agreement </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our agreement with John Bencich,
referred to as the Bencich Agreement, provides Mr. Bencich with termination benefits in the event of an Involuntary Termination, provided that, in the case of termination for good reason, Mr. Bencich has provided us with 30 days&#146; advance
written notice and an opportunity to cure such breach during such 30-day period. We may terminate the Agreement with or without cause by giving Mr. Bencich 30 days&#146; advance written notice, or a cash payment equivalent to 30 calendar days of his
then-current base salary in lieu of providing such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bencich Agreement provides that if an Involuntary Termination occurs, we will be obligated
to pay Mr. Bencich a lump sum payment equal to 18 months of his then-current base salary. In addition, if Mr. Bencich elects to continue his and his dependents&#146; health insurance coverage under COBRA, we must pay in a lump sum payment the number
of months of Mr. Bencich&#146;s monthly premium under COBRA, that is equal to the 18 months. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, if there is an Involuntary Termination,
then the time-based vesting restrictions, if any, will immediately lapse on an additional number of shares under all of Mr. Bencich&#146;s outstanding compensatory equity awards, which includes outstanding stock options granted to Mr. Bencich under
our equity compensation plans, that would have time-vested if Mr. Bencich had continued in employment for 18 months following his Involuntary Termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bencich Agreement provides for additional termination benefits if an Involuntary Termination occurs during the period beginning three months before and
ending 12 months after a change in control or if such Involuntary Termination is required by the merger agreement, purchase agreement or other instrument relating to such change in control, or such Involuntary Termination is made at the express
request of the other party or parties to the transaction constituting such change in control, each of which events is referred to as a Change in Control Termination. Upon such a Change in Control Termination, we will be obligated to pay Mr. Bencich
24 months of his then-current base salary, plus a sum equal to 24 months of his average monthly bonus earnings, where such average is calculated over the 24-month period immediately preceding Mr. Bencich&#146;s separation from services and based on
Mr. Bencich&#146;s bonuses paid in such 24-month period. In addition, our payment of monthly COBRA premiums as described above will be for up to 24 months instead of up to 18 months. Notwithstanding the terms
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any of our equity compensation plans or any agreement in connection with such plans, upon a Change in Control Termination, all vesting restrictions, if any, will immediately lapse on all of
Mr. Bencich&#146;s compensatory equity effective as of his separation from service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All termination benefits in the event of an Involuntary Termination
or Change in Control Termination are subject to Mr. Bencich&#146;s execution, delivery and non-revocation of a general release of all litigation and other claims against us and our affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_7"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of our common stock by the following persons as of
March&nbsp;15, 2021, except as otherwise noted in the footnotes to the table:&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, entity or group who we know to beneficially own five percent or more of our voting securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors and director nominees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our Named Executive Officers identified in the Summary Compensation Table; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our directors and executive officers as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The address of each beneficial owner listed in the table is c/o Achieve Life Sciences, Inc., 1040 West Georgia Street, Suite 1030, Vancouver, British
Columbia, Canada V6E 4H1. The percentages in the table below are based on 6,149,917 shares of our common stock outstanding as of March&nbsp;15, 2021. Except as indicated in the footnotes to the table and pursuant to applicable community property
laws, to our knowledge, each stockholder named in the table has sole voting and investment power with respect to the shares set forth opposite such stockholder&#146;s name. The information provided in the table is based on our records and
information filed with the SEC, unless otherwise noted. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount and Nature of <BR>Beneficial&nbsp;Ownership<SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of <BR>Class(%)<SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>5% or Greater Stockholders:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Catalysis Partners, LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">307,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Named Executive Officers and&nbsp;Directors:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Bencich<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Stewart<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cindy Jacobs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anthony Clarke<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry Wan<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Cormack<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Martin Mattingly<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stewart Parker<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Joseph<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Moyes<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bridget Martell<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current officers and directors as a group (10 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than 1% </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or
investment power with respect to securities. Shares of common stock subject to options and warrants currently exercisable, or exercisable within 60 days of March&nbsp;16, 2020, are deemed outstanding for computing the percentage of the person
holding such options or warrants but are not deemed outstanding for computing the percentage of any other person. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G filed by Catalysis Partners, LLC (&#147;CPL&#148;) Francis Capital management,
LLC, (&#147;FCM&#148;), and John Francis (&#147;Francis&#148;) on January&nbsp;7, 2021, representing beneficial ownership of 307,000 shares of common stock as of December&nbsp;24, 2020. FCM serves as the general partner and investment to CPL and as
such may be deemed to have voting and dispositive power. Francis as managing member of FCM may be deemed to have voting and dispositive power and has sole power to vote and dispose of 22,150 shares of common stock. The address for CPL is 610 Main
Street, Venice, CA 90291. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 141 shares owned directly and 8,253 options exercisable within 60 days of March&nbsp;15, 2021.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 10,626 shares owned directly, 15,411 options exercisable within 60 days of March&nbsp;15, 2021, and
359 shares owned indirectly through his partner, and 882 shares owned indirectly through Ricanto Limited as principal owner. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 176 shares owned directly and 7,688 options exercisable within 60 days of March&nbsp;15, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 2,752 shares owned directly, 6,359 options exercisable within 60 days of March&nbsp;15, 2021, 1,796
shares owned indirectly through his spouse, and 882 shares owned indirectly through Ricanto Limited as principal owner. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 89 shares owned directly and 1,479 options exercisable within 60 days of March&nbsp;15, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 74 shares owned directly, 2,195 options, 48 shares owned indirectly through his spouse and
exercisable within 60 days of March&nbsp;15, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 4 shares owned directly and 2,123 options exercisable within 60 days of March&nbsp;15, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 5 shares owned directly and 2,123 options exercisable within 60 days of March&nbsp;15, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 2,132 options exercisable within 60 days of March&nbsp;15, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 2,132 options exercisable within 60 days of March&nbsp;15, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represent 157 options exercisable within 60 days of March&nbsp;15, 2021 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents for the current officers and directors as a group, 16,952 shares owned directly or indirectly as
indicated above, and 50,052 options exercisable within 60 days of March&nbsp;15, 2021. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc137834_8"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delivery of Documents to Stockholders Sharing an Address </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a process for delivering documents to stockholders that has been approved by the SEC called &#147;householding.&#148; Under this process,
stockholders of record who have the same address and last name will receive only one copy of our Annual Report and this Proxy Statement, unless we or one of our mailing agents has received contrary instructions from any stockholder at that address.
We will continue to mail a proxy card to each stockholder of record. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you prefer to receive multiple copies of the Annual Report and this Proxy
Statement at the same address, additional copies will be provided to you promptly upon either written or oral request. If you are a stockholder of record, you may contact us by writing to Achieve Life Sciences, Inc., Attention: Secretary, 1040 West
Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E&nbsp;4H1 or calling (604) <FONT STYLE="white-space:nowrap">210-2217.</FONT> Eligible stockholders of record receiving multiple copies of our Annual Report and this Proxy Statement
who wish to only receive one copy in the future, can request householding by contacting us in the same manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner holding
shares through your broker, bank or other nominee, you may request additional copies of the Annual Report or this Proxy Statement, or you may request householding, by notifying your broker, bank or other nominee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Proposals to Be Presented at 2022 Annual Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our bylaws provide that, for stockholder nominations to the Board of Director or other proposals to be considered at an annual meeting, the stockholder must
give timely notice thereof in writing to our Secretary at 1040 West Georgia Street, Suite 1030, Vancouver, British Columbia, Canada V6E 4H1, Attn: Secretary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be timely for our 2022 annual meeting of stockholders, a stockholder&#146;s notice must be delivered to or mailed and received by our Secretary at our
principal executive offices not earlier than the close of business on January&nbsp;11, 2022 and not later than the close of business on February&nbsp;10, 2022. A stockholder&#146;s notice to our Secretary must set forth as to each matter the
stockholder proposes to bring before the annual meeting the information required by our bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder proposals submitted pursuant to Rule <FONT
STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act and intended to be presented at our 2022 Annual Meeting must be received by us not later than November&nbsp;30, 2021 in order to be considered for inclusion in our proxy materials for
our 2022 annual meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transaction of Other Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the date of this Proxy Statement, the only business that the Board of Directors intends to present or knows that others will present at the Annual Meeting
is as set forth above. If any other matter or matters are properly brought before the Annual Meeting, or any adjournment or postponement of the Annual Meeting, it is the intention of the persons named in the accompanying form of proxy to vote the
proxy on such matters in accordance with their best judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors, </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g137834g30h04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John Bencich </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vancouver, British Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;30,
2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g137834g83m44.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ACHIEVE LIFE SCIENCES, INC. 1040 WEST GEORGIA STREET SUITE 1030 VANCOUVER, BC V6E 4H1 VOTE BY INTERNET Before The Meeting - Go to
www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. Eastern Time on May&nbsp;10, 2021. Have your proxy card in hand when you access the web site and follow the
instructions to obtain your records and to create an electronic voting instruction form. During The Meeting&#151;Go to https://www.webcaster4.com/Webcast/Page/2636/40168 You may attend the meeting via the Internet and vote during the meeting. Have
the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. Eastern Time on
May&nbsp;10, 2021. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o
Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D41487-P48663 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY
ACHIEVE LIFE SCIENCES, INC. For Withhold For All All All Except To withhold authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and write the number(s) of the nominee(s) on the line below. The Board of Directors
recommends you vote FOR the following: 1. Election of Directors Nominees: 01) John Bencich 05) Martin Mattingly 02) Cindy Jacobs 06) Jay Moyes 03) Donald Joseph 07) Richard Stewart 04) Bridget Martell The Board of Directors recommends you vote FOR
the following proposal. For Against Abstain 2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. NOTE: In their discretion, the proxies may
transact such other business as properly comes before the meeting or any adjournment thereof. NOTE: Please sign exactly as your name or names appear(s) on this Proxy. When shares are held jointly, each holder should sign. When signing as executor,
administrator, attorney,trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in
partnership name by authorized person and state your title. PLEASE COMPLETE, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g137834g35z61.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be Held on May&nbsp;11, 2021: The Notice and
Proxy Statement and Form <FONT STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. D41488-P48663 ACHIEVE LIFE SCIENCES, INC. Annual Meeting of Stockholders May&nbsp;11, 2021 This proxy is solicited by the Board of Directors
The undersigned hereby nominates and appoints John Bencich and Richard Stewart, and each of them individually, the attorney, agent and proxy of the undersigned, with full power of substitution, to vote all stock of ACHIEVE LIFE SCIENCES, INC. which
the undersigned is entitled to represent and vote at the Annual Meeting of Stockholders to be held via webcast at https://www.webcaster4.com/Webcast/Page/2636/40168, on May&nbsp;11, 2021 at 12:00 p.m. local time, and at any and all adjournments or
postponements thereof, as fully as if the undersigned were present and voting on the matters listed on the reverse side. Alternatively, you may access the live Annual Meeting by dialing
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-407-8133</FONT></FONT> (U.S. &amp; Canada) or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">201-689-8040</FONT></FONT> (International). This proxy, when
properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#146; recommendations. (Continued and to be signed on reverse side) </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g137834g30h04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g137834g30h04.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[10(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $^R^40 X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R,S4Y
M.#DQ' (% $!-:6-R;W-O9G0@5V]R9" M($%#2%8@+2 R,#(Q(%!R;WAY(%-T
M871E;65N="!&:6YA;"!$969I;FET:79E($UA #A"24T$)0      $%M DZ@W
M@,79W:DA0M96K)4X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L            IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _0      !( -0    $ +0    8       $X0DE- _<
M     !P  /____________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      S4
M   &              "I    S          !
M  $              ,P   "I                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "I     %)G:'1L;VYG    S     9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    J0    !29VAT;&]N9P   ,P    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
M 0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E
M9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '
M9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y
M<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T
M;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S
M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     0X0DE-! P     "?8    !    H    (4
M  '@  #Y8   "=H &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( (4 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
M 00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B
M,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8G
ME*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"
M! 0#! 4&!P<&!34!  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ -@!! 0$1 /_$ !X   ,
M 00#               '" (!! 4& PD*_\0 *!   04!  (" @(" P$
M! $" P4&!P 1"!(3%!4A(S$6(D%1_]H " $!   _ /OX\/,$DC<]T;7L61B-
M5[$<BO:CO?U5S47VB.]+Z54]+Z7U_KS/P\/$;T#J5T%HH.;<QHA=;T@H%MF8
MRP+D"S&)IIW/A%O=B?"V2=D94\<D=92 ,DMK=T<JQ,&%BE,CZ+J)NV\U3):V
MVZ17;(>PVN9SFGR*9"LI*-M;J+6&H<5G31Y)[\4VI(*@)A_D[2R@*&CFBGA2
M5[9659X>(KY#;*^R.!'#R5A#4[#=:O+<[S%J0.TN.HL==;CUI%T@SU2.>:DJ
MG6%L-#)_CF)#ABD16/<BJ^Z^*&=RU"_4\C,NZ3MU&/+:UG0K._N;:VV5Q$U2
M2*OH*EF.'T5)HY&O$L@YH(HPT(:16?IRBCN8_P#DG0A.J<ZRN[%'<"^]K&2V
M-8]Z/EJ+H664&[J)G)Z^TM9;#&!.<J(KTA23TB/3SA.Z]#U/,N?&Z3%X6TZ%
MII;.HI*FAKF2K! 3='1@)=WL@\1!8^<HVRNL;J<,4HMH<#V#P.D>U6QEFNF]
M:J^K$FD=JBZGF^;Y79:3Y%BT.:S=9S#%N$HB['.XK%R1-FU<^ZB/;',?%:7U
MC^I2#/6W@#-,&'95_P ;\\>%SH+::2/WN>IO3H.Q(>UR3,-OHF$UE,U9))GQ
MA9NF<#2@CI,Z&*,5[XT1T\BN\76R6Z3=\CYH%_G)(T[>@Z1D;E50,MBX9YAY
MR$:B_B6PTQ%0*&LGILZCEM9[=$JI0GAY''RET\.FK8N2\ZKC-CW,2PSF[Q]5
M4I M?C;;/7(ME1Z?>6Y3FUU%FGE#N%,&GF_E[BNF,'J0IY'H]LE]>^27:>6\
M[V6Y['U5_#^C9())Z7G</+H[+E6FMOWV"U50)T ]MP1J0M!-)"&TT2SR)X[I
MW^ZR&09_W<'QT^3_  C,6VYY[H.N\PJ[6_ZO:6V2  U-414%_P#-<[4[<H*K
MMAIWU?ZD5D?<05[R21GF.&FBA;(0Q\:.3KHN,^1U%:8S%==T!$U-57AUAG^5
M;!U2#J"WU1 ];2:;89]CRA:[]V:%9ZRLOJL@E7HAGY!VJQ( MOBCC..?"/E!
M^4RS^/=UFK<!B-!8U84HM_J[OIMD!CMU0;@. B5NG2R$N[.T*=9O,E8=6BV$
M)#'P(Y;ZPO<DQG-Z;'[ZI.B[/E8!L,N #A1MINKVL@:#6W&*1[DAL,SH!H(;
M9MRDBAT8DTT=W*&0'/'XU^3X"WH'7NWW!$5ATK=RC&:*:"52*_/5PS'_ ,1B
M<_*]C'I29^.65%F]-?9V<YUI,C5)CBA<OB7[3T"\Q]+54.'$%LNF;ZU9F,(
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M.;.WO^L"KZ]?S\8P]R/9V]JWZ2 =+U].1^6OI*N1'*TO*YFPBC.N36M>-;W
MPM:,Z44,]9:91$1$1$](G^D_^>:^'AX>'B5UW,[Z3<C].YW?@Y_724T.<T(%
MV&18YC5T@I,I=?'9C!SBF"6E3///_'6XDKIF#3SAS0RP/;]-@7SGH>Y68+I^
MRJF9:1\*S9/GP5E207$4:_:02]O; TJV(KB?Z877@_HQE1-_'+,L;Y(WNNLK
M*^F #JJD$6MK:\>(0$ &"(800:%J,B'&@A8R*&&)B(UD<;&M:U$1$3S?>'AX
%>'AY_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g137834g35z61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g137834g35z61.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M:D8E'F3)ER1*=K>QIP82YG[+980P& P& P& P& P& P& P& P& P& P& P&
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M"\QZ1M"M"K+\1 "H3C\@Q@\H]DF*FF=X0P& P& P& P& P& P& P& P& P&
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MMBE'/\48'):)ST0$8%3BE!H@1@M"V((0"FJ^GE=KO963 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# CVTI\"LH2XS 3(MD9J5QC+,A9&]4@0
M*7%UELI98@T$>^=#TZ!$G^M'TD1QI@_ LG0A> MZT'8C5$35U)&'&00&&G1"
M8H)K+9Y*J\D<;,+9%9M</,2CDAD!ZZ4N"%X4-Y[)(ML(264Y$8I,<O=A,T6
M!"SVQ:>:7UQ$QL%6NPH-/BW>SI1)HYJ&Z2QY3)863%7>51U>\3$*&0*F=&C5
M26,A;4H$ZQ2:J7+2P%A$ I480*1'&/D<JB4?FLVCC3YLFV9VI@<;7IG^$N#4
MXN*97!4:G[/."20B*E*UF,L!,)U2(];/;0-KILSS>RUHXNV4MOW7]>QZTWJL
MU#>X.FFB.(7P#[''2-OICDH=6I2Z-"!OBZ)W%)CTSXH(+:D"_2?V:M^5)VX
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M!\;N$K@<F-F;#-GGH:JGJ<"E)X9+LYZ>9BZ397(Y J,43!Q/UI:I/++/4><
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MY<.9@,!@,#0E:/\ R2.6O]J^Z?U]$X=(^*?%OMPYF P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MMH:&F/M+8PL+6W,C&R-Z)H9F9H1)FUI:&IM3%HVYL;&Y&42C0-Z!(2 HDDH
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M0)C^4-OYX@/QEDI8^*JI+QV?:+)&4;N95FX;N2.L=>Z)6*YD=: 7/1:5:7H
M3RRR_1$:VQ7#TUQ[MA_PNU ]5_<'RM.+E<5VSTAN^0ZUH&!ILAWC*YG?539
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ME (.$I#OP,V(.]CU_CXX9=LE$C3D@3$)$Q"<HLHDH@D@HLDLDC6@D% *  (
M%DAUK0 ZUX!U_A@4R[RMKFJJZ+6INE^FWOD^,V%(XM$([9D$L-=6]I&2\;^V
MKV1JK]T94+L_.#BJ4HPEK$Q*%8G,;1G@5E[2".PUC$S.D6B:LV;AOXP76/U9
M(;Q7([K[<O%*>3);WL1RL6_^D[E?4C1$FE0XKMI!.*Q&U-B% U)=D(D#$TDZ
M))UZ(C=>H6=V>O*(;(MMK<)>!U$@1"= )=H@.6TI&UX$8C-FB2 6;+]P%*(W
M?FV7H7DV+[OAXX84NJ?Y&.+;JO)RYOK2ZVQWN9(5,%B>(KXC/XD"4E0!Q,:)
MT?!)'+HFPQ6Q0Q)>2(#@)C7./MM $,?@  A:-3AE$7,:,:KGY)_CZLUUNERK
MR^H(\N=)0>0SZT'M/&Y4VBW64-=UC%))U%WQQBR$NU("PR)K-0'ND;.>&XM<
M7HCU/5&6$0G#*.,,WH/N/C3IQCN"55#;$5=4-3>S(O+[8QN252]P5 J9E3FU
MN-B,-L1R$R%IC;A'DIQZ1>M3!0'I2C-EF[" ?E$XY8Z2D_G:_.>^J*A;;/YP
MFT2M*EW=;)(PTR**HS@Q1Q/C+LMCLB;D*=:WH"U*)(Z(SB-B 5M.=K7F+$,L
M6A;),3$U/%.*5N;T*8M&A0(T:,DG28I(E2D)TQ2?7F\""R"0 * 3KS;^]UK0
M?N[^YA'/H@C0-EZ)*T 6@!V#18- WHO6@@UL.M>&] "'6M?]M:P.N8VMQRY,
MZ'-Z(UR1E&D)'$Q*0-<E)/UX'DIE8B]J""CM?^L(1:T+_K@?2MO0+TRA$N1)
M%B-6'85:16F)4)E0=^'B%00< 91X=^77CH6M_P"&!\JFUN7(SV]:@1*T"DO1
M2E"J2D*$:@K6@AT6>F-+&2:7H( ZUH0=Z\-:_P"V!S$)4J8H@E,F(3DI2@IT
MQ1!)912<@ 0@"2066$(22@A#K6@AUK6M:U]S ZZ%K;&SW/U:W(&_WJD:Q9[%
M(G2>[5F:UHQ4I] LOUU)F@ZT(8O$6_#[N\#OX# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8&AKO7_6O^#S_(]]_J)9\.F/QY>3?+AS,!@,!@:$K1_Y)'+7
M^U?=/Z^B<.D?%/BWVX<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M^1[[_42SX=,?CR\F^7#F8# 8# T)6C_R2.6O]J^Z?U]$X=(^*?%OMPYF P&
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M& P& P.(H\D[U/1.*-]$T1!OI& ,](X'AL9)GDWOR&@T+7B'?AO7C@<N P&
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M#1Z"'7^.Q;UK7W=X'+@<9IQ) -&'&EDE[&45H9HPE@V8>: D@O0A[UK8SCC
M@!K_ !$(6M:^[O6!R8'6/6HTPM 4JTR<>P>IH)YY10ME^J2G]303!AWL'KJ"
MP>/^'G&'7^.]:V'9P&]ZUK>][\-:^[O>_N:UK7^.][P.,HTH\HL\@PLXDXL!
MI)Q0PF%&E&!T,LPLP&]@&6,&];UO6]ZWK?CK Y,!@:&N]?\ 6O\ @\_R/??Z
MB6?#IC\>7DWRX<S 8# 8&A*T?^21RU_M7W3^OHG#I'Q3XM]N'-X,GB\;FK Z
M167L35)HT]IMHWAA?$*=R:7-)L8#-IER%46:G4D[,+#ORC#O7CK6!I H"K%3
M+&N(A4^X(:6D+[ ^R'Z62]B@[ ^/CJH:'>*(&G2LB2)%;4>L\4R,K9RPE09M
MN3C3D;)$,!Q,ATGG?9,=6=;=)6?=50L8@P:+-D@AO-TH<H,^O4(BZ>?PZU:;
M0SVT9S$&V1*CK5D#Q$94Y*F]I3LOG;B-L"@EPT8,_9R:I,1$+G7[>1E+6/3.
MY')V2&U7+&:X4LK?I$2F3M@I@Q1UA>Z^92WM3K04;LZ%D.XDJ, O6<A)Q%EA
M,,"$&S,1<=U,ZTZ,Z3F#1%K)<9ZF*:&Q%\="1UKX-<,B)-+EW4R>N&JV5SX[
M*R 2!E.;U$^VM:24)B,#8K2; K"J3C]$HU,1&GBKRJZDMXI^;[C;["8[(N)L
MXUM-\F=:I(0U->^8)'+>D.7HW.8V]B3#2BTFJ9CVO5&HY,>-P'N-J%AYVD2G
MR%1:CARO_E:JMKCZ<F\@B#0HMVN&F/IJOZ8LE', ;K:P&6>M\!EM91NKC['F
M4 T&%1Y,T'3%U#)BHYM,8>!M(,)&B&(\K528B(^R'VKJ^SU[1IZ02MK5R:/5
M^LB4]N=QBU>3AJC)IW1_/D,L6RX',J\:F.'S:HJ]KZP7%^2C]$HC1S6(#R2%
M2WK2@%J/)EE>WU?UIS576\-Z6;GR,(+5Z@8D-RL%6P-R<I%%:IK*@I)"D276
MV\4$7*$LJLAP*7.B-%I*[I2!:2@3;$4<028B(OP>#%.T.JYG)DSBQLD+/<T5
M4P>;I*67.\,8%-ELLFY%;;G72R#1MQ6*+GDKP.Z'L3$C"V"$S%-S.M3J-;7!
M,4D%VX_7BFOB^=G6'T-;[\?=[1?AYO+G)"EQEC+%V:-)F)^>)AT\[O<-,+CA
M931L;0I5!,+1&AV[M1*@*=Q,./T$T<3+2.%:NFMD-GU]TG?\UC4O+3Q%TZ[Y
M3K9[KPR(MBQ'(V^RZ?HR$/S\ODYX!R!&N8R7M,I;M(34Z4DU"8%4!2%1X$4T
MG&/"4)5SU/UO9D41.&YC#H:X3FP:#ASZE*+K*6S:AY?8=N+HQ/X"*O&<:IV9
M$3+"P&)T1TR"8YDOK::::%0F,$E($XQ#!;<Z"OVQ:@ZR;I>]QAM9(6R6FD?(
MJY*(&]36LW:L.A(E%ZJDI-7P<95HN+%*H0VK7Q^$\@+(7''(C&?VZ-0$L18B
M(F$UO_6-W1 4M#%+"9;LA;M:+OS-2EG(XS&3D<GNZU:YK.3T\YN3E#$J:*/$
M<KNP5$C87A2A*3H1@-2D*/\ WJ-488-L+W=+2BQ(56$3#7\H)9)A(K?H"N%$
MM61QO?Q)6BP+;A4*E[L4PGZ*:]N0X\\*QIMBU[=,I$ P0!E@V6(S%3.O!2=T
MZ3M=L/*A4^O]EIMCBKOU>SGW](8'$#39])Z8G$79ZVA;DTN20F&IW=UB,B5N
M+BA:4R-RD7U6+ZH]EH"D("U'*'% [GZVM)T@JYXL#=/&6%?,9IE^KQ+5\9<E
ME:M;CQ&S]&216WN4G2+7(R=-EFHE;6G,= JFU*V*AD*$"A846>$5'X_=Y,7O
M^^I^\TJF;)&P0646]%^2FB<SEHK=C7/>TTB3=RK)H<VE/A2]&F-5JJC;CFTA
M:%:C9CUJC>B3@'C+,+4:^?[/)FW;ML1>,U6WDOZM79[/)Q()<4H::\C40M6,
MHNMWWG/W29B=T[E.Y!+E<>AJQT<6^':2)V$2TA8L/*2')4YHVQY?PQMTZ$O:
MK(R=$6>Z5C^Y//579,<E%D6,ZTLR&U@?#99)':FJO=E\Q;8[#(XS3QF5%.R8
MIP!I<H8T@B&D1!9R4P@5$ZURA="A[MLI]Z%E=6VU)XTYR%;6S5.6B'U.[0R6
M5_79;8SUJBF,>FZ]*@!9D8GGVRE2DQJ&[*#6>1L9FCT 2CD:LD!F8BKAA=S]
M62F*];UK44+<77V8;&JZO["B3X5 TS0\M-FL<@=Q2J)->T:FW'P# 3I)Z[TG
M.11I$K3F(C?=*?< ($8^FT#M73/3+#6]6/LOM=J6&7?1]+VE)YJJK:,LK9S\
MCE5U5; K#DS.D*+TA7,##!;(-6&#D.UQ+<M;O?J!?5VE"0LU43PZK6\!.VGV
M%7ZZ@F:2Q4ZGK.[RD<]0-B5J1RY$@6LC8E>""6T!3,K\Y*/11BQO !N7FE"4
MI0 (-+ $SEQ\E+Y)WM8ZR262*(6$.*0 Y;6)R226#&H _/5/$.?:54T!,TSS
M$(:D(618HR SAQ5DM\M5J7Q/M$4N4!2EZ/3!-;8Y_6CWW/K:R"G:.QEXZJB4
M"KPXWL$$3Z*65]"EZ:Z$E,_L^J:\6H35"34 ,]J\V-(V1:)H3D DHF(7U:%.
M>: 99*CIKHS6(]77H_2F('RV1L\%LMPLOFN$[X^-AR,3W*(#:< J]_M2SB%R
M[U+!)U!%LRDC@!P3GA8FQ-$#6YP*,6[4&@$XQRX=6/UM?%_#AD-EB"6LK!$H
M16_QRF&UFRUK'&]AD2CHY\:(G:):I7[/;HQ-S4UNY1[(F:AH@-:I-XJ/=)A>
MVU"HX>+ZC=Z6%4L/@A\BZ(<YZW)>N.F(#9S"H4U,KZ"6F_M)+8S6D6B\*5Q=
M-J10]FCS@6M=V=L(3R<AJ>6]0T&^Q3E(C:5$\(Y+G]B21N01BG8H!](12Z9=
M1<L@C$>3N.D\BDR",=%5;)IS]3MA!H7%U;X_#&]6N=ME@&2F;2C3%'E*\=[,
MPUKV[T%;]F4C-H\NL)BD<EL.H+K=+3J N&-I*KDV7P6;QEN@K2]@:]HI48FT
MZK!,JU*_J!JI*I!]8M1B5$4<5ANHCCP_5;57870ZBV4% I+C5HM%=)/L <K1
M_-U!SY<L@1G(*"^D"%*WFL@H*C=VN>NFDA2\388 QJ)T0:28JV)4(E15]OW9
M1-+%EMG?%[9]DR41":;R?B^UGMZ4,R=6T$;D>ZDDP5:]M1@/.6-05"\G9Y10
M#1C3^;00C%L.A;)&F?FH57EN2RF8M92RJG"MF2'2N^J*@SS,Z$?6)1S;6T8<
MJ8ES^ZR2#R>V1#K=DL]_E<?:&*3FK21LJ8YY:?\ QFN)AOF-S%SJLHP7QU,>
M=N3RZ?1! 3 R.&4LAAD+CL8E,*G)_0EEZA%C/8)X0!:M4-2B+.:-T:!,JHHA
MO7A'LPU>D$$K9FL>'B^D_04[D[#'Y,Z3>-2ZS]]-L\4?^8CH[!RW"ETS18<R
M8&-K]%4@,GS?)WE S)"P2-R4C0*SE7OFTLE*:2'!5>%,9CTLFU].O$4C;NED
MCO8,DF$V>IZ=%H;7_O:(?';FFQ5C]6;=$%C2N61=S;'P>D>RIF6[.A(49P#-
M>L/Q*+PB=/JU[JJNUU=N0HKT!8"1:<\ET?JR9DDAT?4+7):N9HH>]/OV8BNS
MC5*EP7FH3!(V[1HQ"-, 3H8ON"V8F/54*&U%TIT%<\P8JU9K5$QLSO>0XU^<
MI&TT[8LF405PY3>;A+:T3W#&0^FAO33/4!)0E"5*YE)DHC4)YBE2'2G1JHB+
M1);_ $I9=I4^Q)K$LJ/0!0[07AN2,==$1%L]2^Y)85YLJ&T7AF+<-K)60FC*
MUB)3D)68\ (Z8,2QV$I2')] BQ$1/W7P^0MA=I57M'QAFCT2ERM^ZEIYOW%+
M 4.J: R(K?VC4;;)F8S-3ZNVQ#,3A&+6D2D/K%E[$#>M>.JSAQ\E*J\N:>5=
M!JW8FQ[1PTI-7-;P^T+$E41)=W3G8]YZCMJ#VFS&N+\J=#SX12KPTAB;%];*
ME34V)O:NRWUTA9^C#4Q<_71+S-);"C%V7'9<#N=-.8J.><"0Y>J#&X0[-5Q-
M=J21CJ^2R=RD\=;TJ!&%O8I@!4W#CH6](G7(1#4!4D&[( -*B)[L+*[/N6PI
MQ/(S5<T5M#%)'&I"(J[S.-5S(9/5BF4]DUW0,I:U\-B:9...JAP>8K%25HEJ
MM6_$'HR5*D*<&SDH8;8CC]:,D#:4TE?4?/\ #YY<*%?)X?V=:$,+HH^',*"1
M-L'A'+-_(XC<;BY-*-&]IS+(1J27DU6<$,>4 ?"D+>00>EWLRI6DSRI+7?!D
M*BCK7UMRM\JZ9FUW&)TK0\P6N\C1"N$)BV*N0W>E4"4Y4J4= L1[.6W1_P S
M2[E*A/ D7_T\2KWP!C?!#-B7O;=43F^T#?;\A4D2?KRO(\XZERZFV$[G>I)+
MR-&+"8G!D/FS2WQ.-,TTLIGW%TRV0;7-AK@%2 G1KP><::6(B8X<OW=YPZRZ
M4B'U,TSURA2=^B$.K/KJVW"&LZ26Q%3R:@B+%&KG98<](!G)7%Y#8A#J]MRT
M@X\_ZL" DOUB_*:*)MCD^W#LBV4<SYXCYSJO1RZ:2*AGJ<0AQ;($S1Q?7?3U
MPN#1'VY@:ER!3:\MD565XX$E.;@T&(FAL6MP37 Y2(X\@NFV-7?K2=74^O?Q
MY67:_1+ZA3W V6@^2V-((_!(/7;V[/%>-#Y$*_4)E+$H<E:I(2B6&)/47[<%
M!P%)I'IA#HLJ+,1K$1P;))S9D;BU02ZX4JU7)(C'ZZ?+&3.,#3)I@M?8\V1M
M3)"%T/2)%&T,F4.3<3HQ  L[T5>Q@\!Z +S96*UIK!J;HCHFY)FQ5@TVT"/M
M:VZ)I%S+,;6FG;,?W*&HN883;C2E02*'L8J96.;7/I,:G.5($:Y.%$2- ,9J
MPL2S1J8B/LBJR^DK(M> 0(JP[(CU?JGU/\;$KCM2)XBW[,NUPM&XJN?+.E;*
M:XB62\M#%I$0>WIRFM1I-'_JXQ0[>X)4E;+G)8B(G[MB':EQ3VGXI5QT+6%Q
MMOG%K)8;-[#.7P1I+@$;W!IS)D;@%YL_>Z[9%4CE<;;60I4\ -2Z&Y>D6 2L
MY-X5G&+51>.R;F:9YS?#%RIM%8[CKG5KN.&,+C7BVLYM^>M4M1+Y+5RHQ,OL
MN7-Z!-Y%7UPU*D\8:30 )//7;V> HNV*ET8]-)Y?Y?%4B)Z-1FVA)+B='FPF
M..0Z!;<>;'YQY1Z./D]8I(@O;5CPQO30YZ,://,].JK1J TSTO,/TP%X7'+]
M5RX#<]GOG%0[M+CJ::7 VTW-I*AC3>UK$::;SV&-<@);$*=D1'&KDOVO>F,K
M_P!HG,$,L2GTRA;\ [PS,1NKDH1/IS,[UCFJS2=#D736^K#X#E+K:,2K^M M
M_P!J+#Z0:V29TR^-"F,R")*6E$U-C=("VM4E&^-!8PIW@]20J*T,U$5RUU7Y
M[96O['1K>]1ZTG^G2V.Z>;CY%-8]]F"/80M3?M;M$MT]JY2S.[0W19.P.)ZE
MQ,& HC:1.,M2+:(:DHPSCQ4F8K3O:C6&<RJ%.9=DMTNN'Y+%$2I[[%H])C)#
M7#[>=JP96W/[1HN6/#U+I/$AHU !*!(E*1U+ E((-(":<6HGCV=^!WST[81=
M<LB"Z(J7'IO,; "AL^))Z9LV4+V**<_ G2QC=$L-)<:YB;DWV3L TQ9Q)R\;
M >%,I![KRKA1:A9;D&U[BG+BW(K6E*&6&3+EWF[H@L:*)((HCB4FN$RR$TLA
M3"4AV8I51%KW$$9B +F<M=B1&'>NK/",L)-9RB.75ADFG=NNO13W5,$F*&L&
MV4=*2"+/TL8Z_B[Q)E$:CO#]1V4VB JD3<XLZI\U-7316W!<E6;^JR-(0@UY
M"3"1I5S]:JD6-TC9%LU] T]BV3'Z^4/K9\<TH8:N2Q-NT=>3O9UW0!7:,E8Q
MN&U<N)219Z0"1)R6A0$F.B2C5.VU*=03Y#414Z=TZU;T%<&WJI:L*+96P-W+
MW&1P]0V05O;FB.Q*GKAM7?3!1B=*0%OVH<X>@BB5$-0'U?K25&'!\WIZ\"5'
M% JJ])I-X50\4F]CQ>MR!/WQ3J8?1C? 69!JW&:?6%0,OG,[8=%E D#4U1>3
MC7M:8MG$2TL!4>-TX%F:5%"*C55,UW30U]WO">,QS[2R\;C)6'FVXY%=C-!X
MY&1RN VZQW=2M31$+^3(QI(K CV,R:.IJXA\.3($Z$@QQ6:TB3;-W6=OZJWR
M"TYG<S<EDDZ/!(7.--UM5XE?T!C&XADL:B?<W$@F)V,>(<TL\.>5A[:LV4-<
MT)$[<K]MZQ(-:V+>1JHCA]:2V*<\7W8,VMZ?5I8T@96[\RKFZTS(=KFA'&U=
MG70[/4DL&)'1<)YA85)R/F-D8Y.I0MNC"]@DYHA:\J 7IUB8BKA[G4[C(6>U
MN/UB:U)'7L/<[>FT;ES*@,C*2-3LUPHNT5\9C,F6/S,O/&8ZO[24D0)B5! S
ME:@(B=;6 2F%$CA/@H=!KQZ"H+F:J6%+*T\P)7<A<;S)N<E<4B47)IEJF,\A
M%4SQP0+G(9#*?'X; 'O3G[F3G*RT"MO,6+3A(!&IB8W,1,^<MI',,LG\WIUB
MD=CN,7?'M8\3 ELD,2D45E""10]#+'E#"WIR=H-XPLR4+(RG3?6X&G?U>!S"
M?H@)1?@476)J]%@,(T-=Z_ZU_P 'G^1[[_42SX=,?CR\F^7#F8# 8# T)6C_
M ,DCEK_:ONG]?1.'2/BGQ;[<.;KK%B1O2*EZ]4G0H4*<]8M6K#RDR1&D3%".
M4JE2DX0"4Z=.2 0QC&+00!UO>]ZUK KPY];<TM*^L$ [CKY9^=Y_E,7@"]HD
MC.[-#L\0V/N$EDZ3;JWJST*3;6@;MA.]08?!0<25O7G-!K9:E\0WK/F6=0.O
M+1:;BKA'$[*&N1U\ZR*3,4</?52-80W.;:U)WE8D4C6I%IA)*@D&O.68:4$>
MM"&#6Q4LN>^@Z 8CGY'(KIJ1I411S(:I*D=[!B*,^/OGE=%:9I>$ZIV 8VO6
MPQY8:6F-"!1O2(T00>!0MZ%3T>LYW-3;*=%T[O:5;MA\X9QR*&DKIG&DIDM8
M$Z/3B)\C8#G$&WQH+0:T=I2F]4GTO 6A>'W<%2R]JD<7>%AJ1D?6%T7[9V63
M'IVMR;UJK;#)-+2(Z_FEI#C3=M+]IC4 1JMZ]%5I(9HL0O2%Y2,=W9E6(94O
MKP4]@B.:,C$;('.%BDK"FD;3'"2252AX6L.U@'!$T)TR@HTPX902BRC0#%O0
M1AWL5*,':\^:)E7,H7(>B*U;H4A^K6![F\)N",,FHHM>_,<QIP2MF? !CSDZ
M!3[,1A$8 2DK6]@",O>_$M91/!\5[(>;*@4$U7';3@X)=)%Z^8JVV16>UR"Q
MYF\R!I)DBV3NACN]*I$]K'2/$E*21:#LD#606%, ",@L!8UG5E-6WY3%RUEJ
M[*_F\<=ZW2#DZ4^9&K$B!K:2XJXJVZ1"<%RPPHIK2(S6P1HQ&B+!Z&@&[^\V
M'>"8F)J>+]4=$<]-;&P217=M0-L=EHG R,O2FPX>C:I$) ZE-CR-F6FNQ:9S
M$V/2P!"W90A[3*3- .\@]^&"I>3..C:PAECU_4H9#'7^Q9S/6J%J8:U2>/CE
M46 ZPJ63=%)7Z.#6[>2FD3;%/*'>B?/O2LDS7_CWYMB(F8ODS57;50-DY(KA
M=9%=M]D.JE.2G@RJ6QQ+,UZTQM Y(R2XX:O ]*%9S1K1Y(=$[&-,'S@UL =[
MT*GCR8WOHSG0E.C=]WC38$CT^'Q1 Z:L6&Z3.DB;2&U2J8$RX+OZ*QT;B'U(
M(U.$8C"-+"?-H.S0>85+H2I90TGF58JI%/XH)[ALYDJ.!Q74];4#:MLQ 21&
M'0@^+$N9)$BE\0'(-)R$YQ1QC:L<P""6%0:0+0U2>OGL$;8V]3!SF4401&-J
MG9'()0N?VE-'F);'W0]E?$KL\GJP-S<J97I*8D5 -, -.J+$4/03 [#HB"7/
MJVI%-IT54\.D4)GSK>C=.I:PN31.HN-L3Q6MS$"1Y>FWTE"X^3.^Y&XE)$Z)
M('S^9*M,&:7M$, B[9J9Z/(G':U#0J7R>"BE;0Y2BOK"J:"V8B^MFMJ)@ K?
M/VG8I$_+W0].D V("MZVJWH?G!L82_\ UBT'!&,RFC5UTM[:"KOSK5II)9RC
M:2MU6YK&0D3M46>6DVFAYNW'0)$>6L5 (V!)LT03S@%;UHP80[%2RMWED,85
M*LI^DD:9E;-''29+RW9W;&]0U1)L$$MZE*H"M048BCS>,6@JEH_*F*WO6ACU
MA&+I;<IEWECC7Z*RJU<IND)6+G:&II=&5DF3$LI:<UP4N#"6O,<BM-)(R1G"
M,*UL@L0!"\H=AWA:GR1E&NLJ%D;_ &CIJL.O3(76<5K.32.V4TZB"J!GCL9Z
ML"/MC,;(4CF8B3N;:I@GAL)QNO6TXIM$^;SZ\1MEGKC?E"M)HQN=R5.A4%11
M),Q"53Z)$GAA#F-MVW2C7G==&[C+H:[)-)UFO_;*!J"M%B%L8/$5+@57Q4+6
MVO3[)I[7\8B+:\QV.H98^3R$$1]^42R(,LS92D2D#\;M&8YL[P$TA*L"G4JD
MQ?NRBQHS"CS!4^;MHKYHE6ZQ6.MMQ52K>9LB:%\+9D$^B:APE3<^HAK8^NC2
M%,ZC/>4+V@($:A-3!,+5% WLK8]:WX"I8S-)OSA.(_+4\GLZMSV*HYS!93/U
M">PF) 3!)E!)NS2>(;FBQ&[D[9#R9C%DY6TRT1>E1J<:481^ R\$7'FZ522>
ML^@5Z>Z8XW //K1]N>E(F]I'M*YL3DR)YM%TDC=VH+.J.9%S<^.E8M:E$:+0
MSDH"=A#L&QF:V)N-$M$6#72MR84*>;0Q0[R8R7(HPC*D;(8Y/YL&6;13M&Q)
MPK-JG0R'N"?TG8M/H>V\X'E4:+$'PT*E7J4=IT1%5A;$HE+"XRA]C]G26O(\
MQ2:*OYMB,U41-IF+LH9%K [NB- 8O;7DCV:=:(A6/7B9Z6B_*(1=LI>J>X:Q
MNB+))E!)1$9 $M SN3\F8I"PR%9$G)Y84KF%K?SV=6K WNI#:IT 6A[#L98?
MO?$&$F)CBP&B^HJNOJ-R";,+[#D;$S2JV69A6;FT;=5[M%:ADA$0F$[4ID9V
MMQUD+=S2C!!,,,]% L0GJ!E"5@*")B8T?,(Z4BDXN)SJ=HCBSW!:FR"RY86L
M:53*\IJUC?.TC^LDHTAAAZI$_-_1"#2(?WVM!;SA;WY3"M[%:6E1HM^HG^6N
ML$8K.KMYG+$6Z*'J(-4QCCA*&@MC7;:'PQR8TK@:Z(M,KB'VRSU"@^U-V$!O
MDV(.MBI=:)753$^](F#6M6LQ]PL<6P@J+S6-/WN%S4@ Z.:$DMK<E7K*$32:
M%486'6]A2BT=O7I[T+!,3'%UU5T4:V1)#*5EJ58B@KK&$DL;) =-(J3%G.'.
MRQ&V-\A;W/;CIK71YV<'5.G3J2AC3J#U!98!"&,(=BION]IMM"KW>1-T.9[!
M@CI*W>.I9<U1ALE+"N?G*)GDIU**3H&=(N-7JXZH(5%#)6EEB3#"8'81[UO6
M$J4>6%TQ0%9M=KO#_9< ,>*>A;W.+"B[=*HPHFK0QQE$%:HTN8Q.93@E/\RM
M.24%1HH(3EA 1;#ZP-B+$3/F[\9O*OC:A@USSI_@5:L=@-; [$+'*=1Q4P>_
MD:+2EL;$DQ\S<TR!<:D#O01)_'SZ+'Y/, &Q8*FZ>O/KI@<"@,NG.GQC?2XJ
MT6&J3,;0_LVW*0OM9QR02:40YFT)5Z9TE;D,86^X3:\34NDYHC0A"6/81$2\
M".]*\_/4&33Q-;M5(HT2J9FER6[GT0$WQZ3/[>6YHXLY+D[IM$D?STQVQ@3;
M%HTTO0C !V#[[!4L1_;#YX4?;Y6WSR+N#=3LQE,%L]UT^QY$"$NL7KA;9CSX
M)7)R2.3\3IB;AE[ U%+#?5*/$(&B4JDTHNV4FPN]J=L*$,MB1BPXBNB;W'X7
M*DCD<^M:725IL([:2%'N92A4 QK.D3B$:1( [0!GK"QDE^8P.PZ)4QHP^"=1
M4=9R16\PF<1-YB;>JN1LDLI,DL8;6U@6TC)6V,3D+FD<W9*ZG-290XZ4[<"4
MYK>2BV2<H.* K2;/%3S>X;T=SBWQ=LEI]XTT@ASHH7M[1(#K$AJ1@7*V(2,#
MJA0.!CL6A/4L?O2-JB@"V)($P&S- UO6\%2E\:UJ3MQ[R-4@*:M)1/![GHTC
M2':,M/I2)R,5AWZ(B I2]#]7S;UY ZWX^&L(K]#>N.99Q H9:C1<M<HHA8RQ
MQ:(<]2&4,<;'('!B<1MK@V(2WE:C/4*FY:?K0RM:V(KW -[UKU0^8LQ,32;G
M>3Q%G6>U?G^.M:]$PO,O]!W=&U$J21F/B1II#)_36'E&D,;()U3@6+/N$)O<
MEZ,&'U ^)$33'I;G2'-MAN$BMNM=F5M"7"<3YF2RJ/.DC9H<U("G10O<(\E6
MGN_M?:N1 @ $3]]M:1K6O_<%^<L1+(HS>M+R\Z#(&"S8&N=[,BB6902/!D[(
M"1RF*JTIZPEW9F :W3HX(/;I3Q;&44(.M)SON_\ B,\HJ7OO5DUTP2MIA#Q-
M(>@L![;%KA&X6ND+,CE[Z@3E*%*D;(Q*59;JO)&!J.%OT2A!%I*8+[NB1["2
MI\D+4U>L&Z@@<N-71)2QQ8J(UVKD"&3K&X:4]CN"CX7;0TYRA$<$M*4TQZP
MH51FQ@UZI!@P"T7L(L+,3#T8OTES&FD=6TU!K-KI2LF,+E+C6+'$'QF<&)1$
MZI$PLCRD:532I.;$Y+,2Z$@(("+7G(2GB+UL"<S814\99@@O^@%40=IRV7-4
MBF"QE>0T/4K03Z(GQAC<UFR0HFQ>\)G03:@7.'N2O;DC,"8HT:#9>A:&'Q%2
M\RLK\KRT':0-;6O9T2]GG4F@\5+/>V52HGJ.-Q>&2QVD\,)2J1GN4=+;9BBV
M:85H82O$ C-ZT85YA,3#*GRX:>99*L@4BLRO&V7IF18_+X:[2V/II$4P(FQ2
M\KG13'U2X+D%N3LR,Y6,P17DTE),-W_XP"%H5/%AM!7W$[YI",]!MI;2QPJ4
M,SI)&A;N1L[Z!%#R#U!J9>]NC7_].:'#;8C >XH=&F_5IX1D&&#$5L6"8J:1
M_%^R*LE=2L%N,44L0YPFU@'UC&ZKW&&PBWGZP$_UB>A8!,(WP#.W'+H4UBD8
M%3@YI422,BTN5'IR0C\A=LW4I(;;Q*!)*KA$PKB=5[,;8-L #)'WTZ#._P!5
M%5XUI'AR6/+I"9G*68M*ZHEQ>T?MSSS-CWL)P"=Z^Z2D*J^YJS)2N8&& 61(
M7I*ZLK6BC3<W0YM7O;])>JI!R0W(TBM]F#2RI3S[1CIZLPY8I3EEM(P'B'ZV
MQ)PEVS]>"4R.CXLF0VR&Q(G+*T=*:K)GMB?1V5AB[FH+@C^W3!60Y-*V)R.2
M,;\$H^".R,\!*D6@JTOD\1:& 0B4_*BZ!.M^52UB:*<LB-L,&>U,5?YK*55<
M(VE),T<<B\B<HN!C;)XZS/:Y 7*P)33]MH4GNDQX=&[!HL9@F*YOA3TO7;;"
MK)G.V:2A9ZPN@JE) G(;&O2]7,'":Q*$[<6LGZU 0H93'F:IC!GFF$G[(":+
MTMBT$ Q4\$=D]F(SX$;9":B;<,C;G:#)3]=BTNJ$M?94J>;7<:A(VR(QV@#<
M>9TL@;Q*C#GT37OV PC  1OF)"7:EZ?7FBK* 0^8S"!2]#)IW*HM XW6251"
MELM5SV9*QH&2,'/@):"ND1YGH#$8K.>RT.@ \@3AG"**,)$7-0\!YZ$-1/S+
M"F2C[3F=J"AB"<RJO(Z95P'"L(T^.+BT,XII,'VQF:N4ZZ2N4?<"FY&WO*]2
MNTVJ#0EZ()&:$5I?)C$AZ\8&V6 K^)U59D_G8K8D=/@C3".NV8>I!%J=B]W/
MSB)WF,]C;&!D2Q>6)4^A^X]<UQT, "ME!T<(NWGR=)N[:J!Q(NX>V*;H7KGR
MUX;3LQCZYC:2WA:XV!*8G#&.30X9;V<WOT$.EK\8WG+ *"Q@6,B\O9.Q$%>L
M-L_=(L$OE%94@<RX95U@.E;)WF5L!]V&!@C= '9XAQJUH?=L[:X31-8T@90/
M+,:V$NB=B,0*U!.A$&FI/!3A*KQ1?'^R$+W7=3SS5#6RV:OI7%D%#Q%:XTR!
M_L<B4UZ^6DB5)SR;5,BT03-\(C2A6>4]N+<IV,(2$Y1ZC82MBDRP>FJ\8BFB
M:'Q!UU,0R&1V@-RG3MJ4S=CFDYC9$=D)BEY"[O3=IR;X@05'BM(E)J-*U)0)
M$H_;:UYA,SPY(*B7?M(3;<M(3L\];U$3YC@O6A:9[8&H@,FKR80U3/MM,54E
M/JM$X3N%M):';N@,,("E,=40RCCBC!FE%VS^4F0OI)OLR1 :JXJFRIE&$*]F
M89A8R0$ :(7#WMU:&UY6,*C<DG3-(I2LBB5V)+>?J%O=$Z%5L:7U#%9"@@HE
M=5ERRRR@ **  HHL.@%EEA"   !UX!"  =:"$(=:\-:U]S6$?>!H:[U_UK_@
M\_R/??ZB6?#IC\>7DWRX<S 8# 8&A*T?^21RU_M7W3^OHG#I'Q3XM]N'-'UL
ML,XE%8SZ.5I+2(%8+Y$GYKADS5-Q+NGC$D6MQY#2\G-QY9Q*D"%8,(]Z$6;H
M/AYO(/P\@A''7@I36'*%O0>41J=.,EBSL\)^IE]V/C([SJQYL:GA4BY=8^='
MAJ(L67-9\AE$O:E+0)W2B4(&YO4%#TC"!$  3-&IRB?LP-%Q7>#+"%44;WBD
MWI3(^<I/R=(%<K*ECBB:( ?+I:\1VQX\A"R;$KD#LT3,[4ABQQB= N5-S=Z;
MN$M+XF%W1?G:9:ZX_6P5QJ@\UVC3L3774%RWTO7*T2A0^/Z.?UI:-=QM2L6F
MI ^ZGC>GFR+:Y:9X!$6G-"4/P\FL)NN_!"D7X%DD9>H(?*WMJFT#;X'3$7GD
M506!9L';6X^@K8GUJ1!U8(M%FAP;K#;S54P(WIG<MMI:=4W>(35!*D9 "[ON
MSSAF!V36Y!I+S$'%=&9X9.S&F?21,LAT@B%,4X]1VK.2*R7P5Z2ER3;V_P!4
M$K9 X#5%H1(59I_KE!4+-DDDRF/K\L/OOC.Z;GG%@/TXM],979S?>J>,!1&S
MQ\=6"&VASW)*H;(BV4XR)T4//6Q-Y?3EZEQ <YO4D),$F#[/S:+V6)B$3QN@
M[UZ!L><7R6V,=<N+)9M1N\4;6=1<U%M-A(HA0%DU-*O_ /97B#,5KMIC5JT
M[0.2B,;2B B,:@%GD!VX;+<1%++Q?B0V'M2]GC1L19&[5K<83*.I1'O\@<&2
M'<N,]3M"N*J92])A/[XL.209Q):U2@>Q;*7:V?L&S#M9*9W?ND&/4A=\3Y<E
M-+Q2>1F*6*GD,T'!)\S'.AA*B+OUEKIH0%UVO8CU40DSQ''54TG*49+MIH4&
M!7)MJ!EA)U2XW7R07".%)RT(+ ')Y-#W1UF]==EQ-)I<Y3.<*&!;U"ZT\O:T
MRF7S4I1)),@94];'E.RL\)!J\1Q6RTQ1>O1++.4?H]J,<@6S'9[5XMO=4N,
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ML@1/- .ZHQQ9PMFFU2S*$[BC E6-Z[W19J=P+V$9/E" _(1.GW0Q(. 9*]V
MLD+L^MDHADP=K6;9K"2+&LBL4Z&)3?IR:= ,3DTJ88VK_M$\DD34Q,YMBK2!
M.>N0)#R5Q>@#".KOT3=U1SO:UK.4I=JH>Z\;UM@<U6[S;(?SA:D04\>16,<U
MK6N;,A4=1+1OZEG4)%!2AK4#0EJ G%F!5E[)&4>2)B./5@LNX:=)C#)/##Y3
M'F($QO3H&RWB0-#8I&\IX]=/-=I4*D 0(127:Z3,ALX0'G>J:60>B;_1T9K>
MB]:&[FC^2<4WO.Y$]V-('JG8=,$CIRZY1>,5,[V##F1Y#SXTWC''-+)9ZC9$
MTE8_KMMN7W+,8C;5OU&:U)4XP+"RMFF%W0S>-\/[A\-M5E:XS"G0V<-5"?9I
MC5V?9;,XQ5_J1R<Y2-R2W<BCSA8R9=')V]*':.KR4?JIU 0ZV206+8 C=;!G
M2CK?HX^'W=-ILRV[:#)8#<[N1A=:VD_M\S<7[E2OZ&EKVX,]206<O<;DA;O
M#UC>L+;!(5*)<<WF"2&N&ADBXG3E_+ZYUXNGT?HF)()(&(Q>8NT0^/4]Q:?J
M@QO5QA1RK+(O.)/&U!2'ZP);]BVC6)FE,0H4$H%!VPB,V'S#$)RB^VKIP;X^
MIQ!8ZP@3OL=D,[J.0UNKK.4RJQ[,?6*P(Q7-GJ[#31Z>P9Q9E+16JIR.$4I]
MXSF/PDC]XKR@>D'V9@W1Y+1<RP.VZ>6O\ F$6AZEGF4PON]I!.X.N.015DE-
MJW(KE,9K5CC[DE)?'E<F8'M<I=W@X"0HQ6068 K8EHP)B34ZH(LSAJR9-)+A
MD<)L*)1I8X2W3[STJ6-[RH658BN#2U+UR!P&0'RFN%EE2%R5M0DO@%.OTG$?
MO80"WA8RC2_KH]-UXIG"%Q=Q0EZ@*%A=7CHYI2LBSZ_;RH]7]UU!7U>QSZO$
MB;EX5CY#7&N4NAI!A*3*$*D8@J0&DA 8-T+)4O12ZJI<:]^[CP6;7.G.E*I6
MEC1G(=)W.E%=M&+W !/H$I0,JQ%8"0E"7K_R%!2F!$$(?)K#,S?W5V?^3+H;
MHHC25_)JQ52A3#>U*U=S9EJ4D,:"/]66\GM-CE#;]3H%:]U>8,-E1IE;4=I(
MG<M'G; N3>D#9LIK='/LS>C>5);55K-$]=)/''-K;6.P6D:%O(<BUYADNK?C
MR%(#0B4$ 3: E6\X.9QVO'QV4X)=!\1!-T&I,W'UW5TC_(%HW"T6'%IF*'U?
M ?S[?(/(XU(V>//J6WG4[H)TO6J6Q6[MK@F;604;#'+%-?R7$AP/$^%)6D'H
MIP$B.,+NB/&H9?..,KOLI2Y3]?)J>K&V$<<IZM(AJMD,G40YL@44)M&(6>\G
M#<&]G<TTBD]:7>_HX^W%D&I8^H2(?,L5A$886-T1X/+<OCZF:!0O<(=,HZVI
MX#=$6DU P]H=Y;7:!@I-C9;9.,JQWF$72N3U&EZ&:W_(U3<L;T2Y.2B9V0@P
M@>BC?(-RS_-7,J>@I#+W5 G8T+3(*WI*#M+2A=G^4.K&76:*;&NK:JF$G3)W
MN0,OUW-3S&X9^@&!*$/S%%>.@:),VK\_<3VB^,2VNA22L4L,C#UUQ-(#--(I
M ?9,ED?4$2N".%,5@$B1%MC6Q1@^Z%BAR6HUC@H?SV9M-VF1B+&'9=T<>>GX
M6)ONDIQ/J=A,2@"I@;K1@@VY9";&72Z5PU;6TM1PA\B!5@1A5&6-^4/RM(2]
MGD*&-P) UOC6J4HE@]$G"ULD3KV5MEO%]XR@+E"C9Q5?V W+>GY\FDYK9)M3
MAZDG2E,6E!525SC117V;8VR*S.T5:O8DZ]6-P;BRB] 2FECV>6,H\]'5<.-K
MR=6)8_&*J<CMP-%?TE657/\ 7DEL&"-%;'TM%[@9FRYVM8ABJYP629:=<*U#
MN(J$QK&9&P&-BI<J*4FBT-T>22#^3++=)H[KGJ90Y2Q+;@E5K ?TR5W(DB]1
M/>.W;G"2)E4;]K]3-1J&7GDNR7T'$XLU <82+1)A(-G#=%?75'V^/^@OLVTQ
MPE^IM,7(H/QY%;(6F+IHO,:%')UD"DII\)(W'$(7PBR(QY20[7C0#8E^A"\'
M$H6O(-T/5F?%5ES9*ZM:R4U\A1-4GZ?D<-.-3O[XF?@W5T[474,29[ CYZ-M
M3Z8$CU %D=D")*L4!7M1X3RC &&F)RHD91#*XQR9/%]ZNE_V(HK$A\E +2$Z
MPV,%/#XQ1X^65?4E5L"IH?'QC9E+X\KF>NU8GMP-0-XSDJI,A+)&4E$:=3=%
M4G_G%BL& 0A@IR7QI"D9J8K6FJZ8)XC>0JR;+=V&N6=+,WIM8A)@+6*/M;L4
M6D2B5F>Z5' 4;V466 L9I)ZJ<M_&%XQ^+*F-K=Z3?E;U15D<PNPYB7+7!J05
MY)IW(I3'[!:4!;&,9\A6H)0:3(XL884WNAB!O\CP4!+]^:W1=IYN_E1VL.$4
M?#HK,"D9E>)T=8SY]E/O5KM.^>I.P-<8N6';4(M;\LFG+='FX\"DW6R *TNA
MCU_AX$C*D4NO%MC/J4^OE<BK-LKN/S3JVQ(;-$#4^*[1>7KIV*W''-QR7MQI
M*)D0,L0'=RTY4L2N"LY]VR-GBG1; 9A=W-\0KB^=)[C8+*L97'I VJSJ0F+\
MRL-L6BSM\(LFD8$1"&@Z,1Q-'D+)8T<7F-"9>5];":#4ARY>6:4L+-#K!.6E
M0SJX>;;OL_H"'S@5F-?YJ(;8U.V''HJI?9>U#CI=>F+SI;'PPI@2IXM,G.:+
MU0513\\K3S&PO7M"$.M!"IV2)B(KF]KGCEU\J"KK#@$P4PR> FE>U/##6DPM
MU)C;J& \TUS2#ZWO_N$9BKZCDCM#5)O_ (RC# MZH.A V;H0<<B9ND.?L9W>
M^Q!)#958D; Q.%:]44<%!]HYC,GBIJFOZ.UDBBC=$IW(61MD-L.->O=;C$'<
M@+;3SVYVTGVK%MO+&J+NCD]!=RE>KU:43Z(<#:%:[,K@=6M<9JV/AF">H),Q
M5]%+LBBMTD#X<P:?8[*-E7DL.CPD[0Y%1PMK)3>9<%4<<4-T57)(5(<R6)5/
M0%J7DM?86YZOJ1KW2PHT,U[=3H8C2Q.)I(T55DA7M:12WHS)"R*POK680F0.
MWK)G,.TRU.>2M),Q,5T=%PY5L%39#N$E\@.ZN?\ J>'=8+).J(>C+@;I#$&F
M,$@K]N("B^H3FM>OB)"+3V-P+/3Q=6H:-(#->55L;HKO5,N4<VS-9QC"N4]3
M9*S+@UO750V+-& 1Y"DV"H$S*Q6A]BMN#:X!3/DCB"9<A;35J<9*8U6$XT ]
M%[+&+C=N1DIXVM&*6.YV17=T'2AU33:#7-&BKG1M*X!EIL5:32@YPT.I==1*
M%H&^%3ZBW]L;RE*5.-P:7AC3K-EK21#2;+NBJ2%8'-\BZ$EO/\LOI@K7V=4N
M=K+Y#"XU(IB_M:X<QC*2/1=4S2!6Q0E>>L;]%&F*]'I""M:-\I>A[UH6$B:B
M8A5=5\<DS;X2XQ-D7U>\-!.X06S0MZ<)FRQU:SPWOZ6];%QIT?D#4^/C:A5P
M%^(9-*2B%9Y;D4(S81D^ MEW?7E2P$OY'D,UWSZ:F)K^M6R*D"@][P./N4FF
M+#+Z:0RYELYEA48D3PTQMS7J0SV#-A!QCDB)+TQO;XG#K8SBA")&5/>I/F^5
M5;T1>5GN,5JUQ:K8L*4S5#83?,)L79*)I?(W!FI)$G*#J8EJ'"(2K8H/8U9+
MOZFR?3WHO8MCU@F;B(84OYFO)>T7S6^U-3DP&TNB$%\1^7:DDP,F" *6S*NG
M@XR\PW<' R@$)+"UJ?2LA[-UZAA O1\!&: DN-)YTQ!V^/W23G?\W4<::W>+
M"=+_ (Y<D[.D#S-&.(V$V1[HEXN4J/.3FVH'YX8U9C,["3:/2(! TLUO>P;*
M\-Z2N[6^5+7R&LY$Y\]-U6@J6C) :8UMC"^U/,Y-*'FH3&),I\QK<FDRVOW.
M0+Q(0$DGI3E+%H6E!>ON V$)NC-ZWJ@NJ^<>AZ",;9)!I=6]E2.15\Q0:R6"
MRGBP6AN1AA<PL:25N=![ TEL28.+=!HS9!D8&4^I5:UW;FA K,6)E6E6E)9F
M)8/:G$T]F$ZW.0MU16(E'TK,[O.@DYDTZA;0:U2SF*"T@0DU(XO%I.Y%O;/)
M(J>L"'V@DYR%0'6QA-#O6%C*OL^)OPG8,@8U#G')I"XY8BOIT-HK3SDKXY1I
MSI&0VY5MF3*K'$84Z-P-?&Y;6Z9>R.&B?(0Z) !$$"=8M"(1E^BRU*U?<M-)
MDU1$**UD5%L2J5@B$H-<I,T6DR19X5N[O&X@YQ4# Y120*(LI<2V_P"N NZ(
M:Q G":8B"IV/8R3,3-\U:*FX[G=<\NM?/SI1W*DM,1LE<QR0@>+&M-=&YT=#
M8D8S'V&>-;59[K"9DD?4*1<W%-P3A)Q&&"*6ICB231%W:W<K=T"S6Q$HF&I[
M*&LE *SA=>Q)NN=Y>?=N]Q2'<5T?,Y 8RFFN+LTMC,O-3HB5#BN5N+@>!0,X
M0M@T>H,S7&%&#_CLL;5$32$-EAPINM<F@J&KZIYB)N?5<>8I[57/D@HV9#E*
M#RIERZO[)9Y*N0*B2?%46VJ]G!"%80GV&-;XN^5K34G3MVT"IU!XPLJ^6T\]
M2D<Q7'/KE*8]/(,XRC9+G8S4Q)F^.OK)/&QSEQBYS;#5BED/1 7^U-T> @!H
MJDS$^*V3".0#;O-)T[,E=OK!Y#HIA6+5[=]5 >%X(^;[AP0MRGZP4, 4IBPO
MTO3)6"-++&:6$!HS+V<#0UWK_K7_  >?Y'OO]1+/ATQ^/+R;Y<.9@,!@,#0E
M:/\ R2.6O]J^Z?U]$X=(^*?%OMPYHONN>NU651/;)98X&6JH''5LM51[WHV\
MYR8V#R.4E A4%I%HA.A$=3JC4A7I[TH4EEE;V'0]BT6(N:52C/:1D[GKG73-
M#T)'UW9#DSUQ)4TI]\5+J.9H?81TAO%*0F:?%.G0V-5+VQI4@##23]'M2G:H
M 5VBP%V\T&USUE:S5S1%2K8C839:'D[FZZV:3QBR5ZN325OFKK&H6^[FCTXP
MT!;5,3'4P#@H,2%N"56!::1H81%>N=%VQ>G64L75T#:LFHOM67U\TM$2B%,0
MWH"#QN4I9@X)K87VC6$95%FO3<TD,86.)L@9. U.A,4.!JPPD@I?Y E'EEY2
M(BXA9>F+6F,UE%M0"PXM'8S,ZJ>XLG5BB$C<9-''1EF\722EB/(6N[!&W AT
M;PFGHU98D^RAC3A/+'Y3O2*,S'14WJZXN@8LJ[+9(VX1MNAM<<FUE9-;J(\O
M=F>R2+"E\PMUE.V>^&H!,S>B=-P#V_F]0S:0!91H BV:H""+C$:>++9EV+.8
M&C?XF_5LQJK<0] QJAF=)%5MB36%+3Y=3!M]H)0H)B=;O%DF$-4(0K4JA&D8
MU(S7),#>C24QXC4](QOPI;NG9V[V;6$*GD@@\BK5]DK*2O>(+*T3BW/L:<@F
M&IEK>K2O#8RNP2=*"!#3C5(D:@U,,LPP@D8ME!),5-*DJ>VEZ>KV>PM5XA/5
M.G-G6=_?4()4( PJ.9WV%,R:,%*S&?6Q)Y;N7>)JT18?8#*"'TS?/XAEZ+MU
MKO#A4=;VRV.JBLGFJX$GN=WGU0Q"()D5AO2NM@H+BAT^G2)SE$C/A2)^2K(D
MS5<]D*$R5N/"YJP(@D&DZ6#]K3;''DAIA[/MF!P)@:3ZU=[8MR23GNV8N,98
MS[)L()$1Y\Z??X &OH6[5S6,T<5CHMW)&MJCYSHB:FM&E3ZTL-*,T60,NV+[
M:+%OG2]Q#<^AOL11I,C9*3_-HSMR4;X_GV%(I'847K";.ZI57[#$7AR(9:TB
M4[5K%Z1 :XO;J<W^U0)!'F!\25&G=C*_KL\H"V0Q! Q6&N?JHY*4PX31-W-'
M6+O-^C[VL"E6G6Q+8<*01MH8Y$B).=UIR8UQ$D*TEV@*5)O*<*ZNNT=87@].
M*"O4U4U<5::KI>Q>=U!HK.?U%>I"(%11UV%ST3@F@@Y&9IY2EEH-LWLPGI#S
M]>=2()0Q[&V./*F-*/D"D;GNIBX/0\IESG*ZA@5S3Z-,#?84P>&9DG,W>(#J
M/PY=!JWD3$O=F=QBSPM&KD"B.H3TB(D&A &J,&C&U[/[0%L3KH/GQ*C9F6*4
MT]](],5*4<VSQ4HE\N44775ZQ9TW-(>-A1-@8^Z3N#'N+:6F7JS4I:!&<?K0
MU/D3EJ(B>M+76K.5<2F5!,R-"Y.!E@6;)XQZ"![):"1":J*N&>D%N2<]"I)>
M4JI5#"R2R!'(PE*3"E.S=Z(V2:9B+MX/--SO=U0IU=I@QM,*GL>?],4UK1,.
M3ZD-;.REB9)"1$YFFED;BZ[;^F;WLHP*U&0<SNR,PA<WJ#TB@L>Q,4B]CZQD
M4EZ1?Z>8*FD;M!8K92NGY+/$4?LD\4?E*.I$-L'2UY> 5[NJV^!^+JC8 @')
M=/(G-82=I+[<P/B6M+5V?>VN@';GJ=S=JKRLJ_GSWQT9U;4!Y\P?9NS-;.$"
M(AR9)RFU$&38I&W!=DBI%[32E$I&:(@[982-FGEC&+KO22KVOB[X:&W6RNR8
M@ELB#;XG*<3Y4\/;M7AGY[+6=H3+DL<8TD>T\-P_*G$3I2:8<8H)- 9Z9)J<
M(321$>6KR'SJ2;5;*K2BY36OL"8S3KE;5]?-JY'8T@CD/9X_R15ENR$D#?6<
M%L6;[9O>)7$29.D:C->\<A*#AEE .%A:B8\OW8GT1UI<CU4$U-KRO556N,9H
MSGRU;(,FTL=H1:,!7WU+W1H11*.,@XL(DY^@Z>'N&W7;@H;A*C3"T:<O1VS=
ME",8O7JO1T],9Q7?.5ZV!6IC 3/(-4T^F$7/E!:D]A(=8U&7)Y)4."=(4>>I
M+("B$,!7EV TP(0#WH&Q;T9C65:YCUU9<#1S5:MKR%/[?SY5M56)T.O)F+PP
MN*W5BIWA<O1TZQ+8NK^NMQQC8#UH-NJAOTZ*A@;B/(<$XXHUMC[K/=$VLY4A
M2\\M-GC),S=HDW(5+9%E#QJ/$/J]P>6UF2-YSX)"Y!:BSE#B'Q/VG.T7K7CL
M.]89B+FE<1]<V*DO=%2(J95R97%G*HHO<3W!&ZTY&VQZ16XW:<PO<<>D]8BA
MA<"@:%2D4NBI_=V5:<E//&2F\R31:HNW2V ,'>-@"K=59LMI^*)&J1\X=']
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MUG:M4,6A$P4Q@V6Z1UY""V1TE<A2P^02IA;E+X[N!J).4%P4'#0M1!P_($T
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MPOB#FH6M1^M#1.9*Z#2F91XY*N)%H8-%KAFE_= : LP(@:),5HDG"-#7>O\
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MTZX&&Z=.3*MCYI94C9J:%0JAG*0OD;>46XV^UN<>G5E# -4%4>)0G4$&!+V
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MNJF4)DK>_!6/2!WJY^CDXAJ20JG#ZT<#B5QS$D&I]QO2E8E,$+1FA#T9A+I
M*[A.KW0;\F<9M;"J-.<5O:%L4-W((V3'(,P=&2=HF5EDQ@)$/*>%*L^1,Q9K
M>>[K'0QL(&-,1L*??I:+NEY*;F*-N/0]0SIB7HU4,IAYZ3L@Q2.8$NSS)+3O
M>P7IR?8RY1E SIV\$5KB2+G96B.4JC%2!SV20 OU2E)PA>GV25T/R37/2JI
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MB:#E^E>>9)3M=*[:Z(FSL@F:A)7437MM3EVZO=K<Z=71,X;*I01%MC4)1N3
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M.F='-*!R3K"M8:_]1Q^NK85813RAH/D]N=6^6,\8W8/,;9;+;-W(I\F#6Q
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M4^+?;AS>:\K%K<T.B]N:53^X(6Y:K0L2%0WI%KRL3IC#DS4D5NZMO:DJEP.
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M7QZR*CKJ2Q)(\:;7)A-MBW8S4"9]6>NA4C/:6)ZD!@CC""S"C#D9B;U '?\
MI%),JVPD5H0INEJ1 H9E(US\P2!@6&@/61J7P]_<XE,HVJ/*" M2:PRAD5I?
M6"$(% 2M&@UY!AP3%)"PA@,!@1N945=*9))9<XQI.]O\L605<[K)$K<9$4 Z
MLG+;Y 2V9O>UB]MCB2*2(PQT1D-Y*4DMU-,6^7:HP1NRV]>0P&+2N00N32!
MH<G.O7-Q>XF QU=RFEN>W)J4,AKTH8$ZXEB=W9&U+5!*-0L3J#4&E)PDPBAF
M#%LC,<!@,#')=%6><1E\B$@TYB8Y$W*&EV+9WU\C+D<WJP^FJ3IGV-.+2^MN
MU!6]@$-,I),V 6P^;PWO ]-I:6QA:FQC94"5J9F5O1-+2V(""TR%N;&Y,6C0
M($:8K02DZ5&E) 66 .M!  .M:^YK ]# 8# 8# 8# 8# 8# 8# 8# 8'1<VY,
M[MK@TK!+ )'-"K;U0V]Q<&A>!.M(,3'"0NS2J0NK6L"69O92A,<2H('X#+&
M8="T&&U[5\-J]$\)(DB<P'2-WT_R1ZD,EDTTE,D>@MC<RDN,@EDQ=WZ2O*A(
MS-"5&G]PJ,"F2)BB2M * $.BS-O3G4(CED1)[@TO2K5T8DB3ZN?6Y"\O3"8Y
MM@S2S%;6I<(^X-;GML<RB]D+$X3M%+$IAA!P1DF& $3@R@@@E,22F3$E)TZ<
MHL@@@@L!1)!)0-%E$DE%Z" LHL =:"'6M:UK7AK Y<!@><[M:5[:G%F7#7%H
MW5$J;U1C6ZNC&Y 3JR1D&C;WID6-[RTK @'O92E*>2H)'X#+&$>M"T&)5]6<
M.J]N=&Z((7$G;\\FR*1.S[(I',)-)'XUO;VG;O(I7+W9\DCXN+:6A(C*&J5&
M^@C2DD%: 246 (F;9]@,!@,!@,!@,#HN38W/*!6U.Z!&Z-B\D:9:WN"8E8B5
MIS-> R5*50 P@\H7_4(@[U@=[ 8# 8# 8# 8'1TUMNG,3UIO1?7 D(&L3K[4
MGZQVVEJ!JP-^UOD]Q[(*HP1FBO-Y//OS>'C]W [V P&!H:[U_P!:_P"#S_(]
M]_J)9\.F/QY>3?+AS,!@,!@:$K1_Y)'+7^U?=/Z^B<.D?%/BWVX<V(6 EG"Z
M#2]%6;O'H_8:N-O*:$/LL:5C]&664GH#RF-U?F1O7M2YW:F]Q$6:>F*4IQGE
M@V#1@/'S:$5>O!1J'\HW%$(I63DU2.I4-QU%8,PFZ"3KFZ<RAHME7:$1=8[:
M3U;:Q6[,TC,F4H>'C3L6K;S I49B!,B)3%H-!(*-7'DE&%<JFPA/R<D23,MT
M_9U>+%D<E7JV7:11/Y#9D(F[)(W-"E3N!Q$;+4RR;J'(*<0E>BB/!/H8MZ]7
M!NX]T>VOPRRN[S%916!<*<WMEC5QPA>W].E6-T>Q?4-X'5^KDKLQ&SJP'!^9
M75E65NATE0$J@-9Z)2L2^1-Z_K@$9=6&M? +ZPVA74M1SV)OQ4"-H@+3;$MB
M;XX]*16*4O#HC$GRHX5/4\K3LK?5]T_9A8JDB(U%LHXV3O.S2%9IZ4]&7<]R
MLOC[AS7+)7,K 3M#&:Z0TJMXO%Z&E]V5JAB<,!,4LX6)&R8);**F;(@<7IJ0
M>BQ,1S+'FXA*,L"4_P!P8/0G*V-27X\E<QLZP9"^3.)E,-@G6TGD-AML5>/V
MD)+7EIUI(ZY3T#++"7R96T/5.P#Z^3N#2D-1#*T:R-_BE L H<E W:,_1\<3
MN=2=/8UX78N3V,Q!J]MC#G13"UQ!C"VU"@M J..LC8[*1VH@>WUR?;?=W;8!
M%:(:E9:'V@MG)/=&DW5I"+(K\?%C0ZJVNG$-Y-LAB\VHVL*#OQ\EL,THEKK$
MZR?)FX$*:R4,"^/,C&I?(W/W)AV!S1K]HTX$BO1AYY!Q:HLY1,W2QO3W.L@N
M<Y[#&') UBL3G>^.;)4XN !* Q]KM)G;'*,35.@TH2B=-1J4QL*92B+,*-4I
MG41FAZVGUK9(FON\LSD96HTVE#F3>F*(O_I.YEQR-@&!6>AON!6["4K22+;A
MH/UM&@V82<8J'Y@*0H=@T OSAV ;OTA%,!X4D[!.H#+IK*(O,TB"-<^M\W8R
M7JYXXSD2SF;2@%=S&(1QDL9%$7D2LQ*VKAHY$WN.FYR2FFE'*"S_ $BR[NC*
MD?$C@DK-G@()FP!/:>#)1QL!Q*BYI1'UI)&]A1FS4E*%R\Y+-ZS)HPUNT/U#
M=[#XG>(?'";M?.V)R'A6R)M84FD<QO$3JPJXG?T-BX3R)RXN++'[PK\J#M;(
MDC2^>?FUCK=5Y!7E3F-;20N?0:T:L/+4;/&H+NADJ#DRWF>:LMU-L]K<=ML:
M^.KRFAQB\F55RM+#1S134N1BWI_#)4"E2-D3N38O ,T],7H]$: TM68< EQP
MY.",<)K8Q!YE$"Y^TN1\O8N=D2MV,BAC<5IXI^]I_>DK4)VQ,\'!;H_(GFP5
M25G;BSAZ94P !V:H\-BV7=^_Z,=9^&[2'8"JP9[=A<W=4[A"=)EBXF=.;L_-
M4+ZKK/HXLY8EDD]<HE#%2AFK[4?3MD=;VUI2B, JWHP 0IRB;ELJ KV=UXQJ
MDTH,C(-2]YG5FR=N;0N"AT:['LZQ9/.7IG3.@E6VM9&(VU/B5L3C"0 ]0<C&
M>(7E-T#1)F)6%PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:&N]?\ 6O\ @\_R/??ZB6?#
MIC\>7DWRX<S 8# 8&A*T?^21RU_M7W3^OHG#I'Q3XM]N',P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P&!H:[U_UK_@\_R/??ZB6?#IC\
M>7DWRX<S 8# 8&A*T?\ DD<M?[5]T_KZ)PZ1\4^+?;AS878D_C-5PB26',C7
MDF+Q)M,=GLV/1653A[ B*&66,3;$H0RR*6/RGS&:\"$"%2>+7CO0-ZUOP'%2
MJMOE(XPN)VKEHJ^?S26CM2V@TC$',5)77$F!;8P8Y9<F6,?U_/H!$VD\3,CJ
M)^(<1)S3]MJU)I.JT2:86$1J<,HXKH'6$P$62WU4--)MRASA+K/TRPN'R@V'
M!8F9\:(\L3*YZ6TBAB*2#7O1(B&DY<!S4I@FJ"B!DDFF )6ELYPA@-[UK[N]
M^&O^^_N8'YXZ\?#QUX^'CX?]?#_OX?\ ; _?'_\ Q_C_ /# 8$.5A>U>6_*K
MNAL)6N:M\Y[LTBH[++7,Z]L3()JH@4+LHM&U+%919#VB^RL_;3=J4^QE:--&
M5O?G+%K19B8J^:8\(8# 8# 8$-TG?%==!,4QD=:KW)P:X+;%HTM(3'-H7,QQ
M$\IV9.L"FZ-,0O+*,5MZ21LQY:=6#6R510=&%[V$6MX68KBF3"/SQU]W?CKP
MU_C]W_#[GC]W_M]S _<!@8@U3^#ODQEU>LTMC[K.8"@C#I-XDWNJ-7((DWS4
MMW.B*N1-9!HU;03)2&%88BV>$'N"TQ@@>(0^."IX\GM/KRBCK(\2!S$:!M8F
MIP>7 9!)B@X*)L2'+58B4Y6A&GFA((%L( ZV(6_N:^[O P6E+>A/0%05C>=;
M+%R^O;>@<6LB$KG-M5LSBKBTQ9D;\QJ5S2O 4M;51S<N+$80:$)A0M["+6MZ
MWA9BIJ4GX166:=;T[7\ZC]=RDV;MDBE-\0GG"/F*:ZFB5A>;.L"LGRVX\E9)
M*M9DK#(([J(1Q7[QU;U"M @<"MH5!A:O0B@EVS,7R8D'N_G<?(3/W&%]DF^?
MGU#&G!N>_L>^?:,Q-+)^VUFR[,B7MOKLH9TL=B2AAV7XEE;V:+[S6]X7;.[;
MS7'PR8# Q!%8$'<IP_UFWRV/K;"BL>CTMDT*2NJ,^3,$9EJU];HN^O#.4:):
MW-<A71AQ*1G&@"!0-$=H&Q>F+P%35\GN/3NC8&9V?7$1H6]D;%[NO$22-0<%
M&VI35BH11!6A&'FZ()%Y0!UL0M_<U]W>!!,4ZCJF;4!4W2\8%-7NK+J:JJ>H
M(I9J\F;])537<JYA00M>ZP]@9G61LB )DD3&N:E2G+3,Z71JA882G)-, 68F
M)KFL3A%<KXZQH?F^+VC)[0G;>A'3=4#N^?11EUN03QIJW3NL8")B"&->SWU2
MSKGMM4I$YH2?(>H3&E@V(18]:+$3/!8@@X"@@E07H6BSRBS@:&$0!Z :#0PZ
M& 6M" +P%]W6_NZWA'+@,!@,!@,"L=G]<T[4=FGU!+#)RKGA%0&7EMDAM;S:
M?*SZ^*LZ)5$<N1(X6ROCBX.">939 $U*008<2AV:K,T%.0:8$L8S,7R6<PA@
M8? [!@UI15NG-;RV/3J&NYSJG:93%79&^,#F:QO"^/NX4#JWFGHU?U>]M2E*
M;LL8M!.)&'Q\=;PLQ,:3Q87<5\5U1/YK/SAKG-#^>2Y(/0\&^K6=>\>[L6Q-
MN>HPA</8E&_5;8HVT'>JL.\I!'AKSBUYM8(B9X/TR]Z[*Z"1\QC7.7YV5U..
M-[IVS3.NVS[KMJFS77RQ<)_T5]6 <@R5X(+"CV/UQ%;V9H/D#O>"IK=R3'A#
M P:*6&P3-]L&.LZ:3$.%:2=+$9&:^P^41ML5NJR-,<K)/BCP_-+<US9E"UR%
M. ;@T'+$):P)R41NE*<\HL4SG IE)._.96%S:8^WRV13>5/733WR$BB%?U].
M97)Q7O$HYN9SB,C:$+!H_3/ X8 ;N\/.O,T(T!0S-J1;#L.&ML_BUS<,F P&
M!#BV]J\07]'N9U"UTU:TGJ.5W>U-Q;,O,9QU_"Y?$8,^KU#^$K;:E7DR&;MY
M9:48]'&@,$,.MA +>BU-7R3'A%9ZLZTI^Y)8XPR"&3=Q=FF?7Y6;FL/KJ:)H
MTW3#FR8LT$L]J=)?MF'%F<\J0/I(6D"Q60:^$%GG(0'EIE BRSC,1<K,81A\
MZL"#UC'C);8DMC\)C!;K'F,;])W5&S->GJ6O[;%8NTZ6+C221.4ADKRD0(B-
M;V8I5J2RB]"&,.MB(O@ZT+L-@GJJ<)&--)DQM?3=QK]^W(X?*(F2I?FML9W=
M2IC2B2-+61+XT-(^$!)=VP2ML/.":46>(T@X( SG P:36&P1.45[$'5-)CG:
MS7AZ8HV>S0^4/[(D6L,:<Y6N,EDB96E<QPAO,:V@T"94[J$2=6L$6E)&-2:4
M4(M6SG"& P(;AM\5W/;@NJC(ZN<C["H!+62RR$*IG7(VY 1;K$[R.%":W<\H
M*%ZVK;&-0(_2<0O;##H!G@(6M868F(B>4IDPBMMB];T'6+F@8WZ=H7)\57U4
MO-#BRQ0 Y0ZQ6X;O+:U5<QB9(6?:D^+">6Q\1K1&+-%!)0JBCQ^!9@1;+&,S
M]DLO-AL#%/(17*Y-)C)#8#;+W5A5-T/E#K%TR6$%,ISR"2S)M:545B*Q0!^(
M^KR'-6D.=!!.TD"=L@[0"5I;.<!@:&N]?]:_X//\CWW^HEGPZ8_'EY-\N',P
M& P&!H2M'_DD<M?[5]T_KZ)PZ1\4^+?;AS,#^>>._&U=$HYYX4I2X:Y9W=DJ
MOY+>G>A+UC.Y\UZ1:HVR)'V6]Q%6):SNZ<R0E/\ NVX[I>SI31G#)6GD*2]E
M 4@R.NZ+F8Z?\( W\:/71],06O;$8+F,CL3XTZ$HA:CI*Y*R>K+2.CE\AL'N
M&BHDWIK5G\?A<WAR?G^))DSJ@=75.E4L!)S*8H <:$O=7=C?*[_98'L2&7G!
M/@#DT%N&OX)5=W-,9I]A?J[H]R,AL.8E:SJBOT[&U1YRC+R_IX8N=8^K2"<1
M-*]:A:G%2ITA.-3%$B$3&O[-.'\(VB7QK7;/YLQ(I!0+U2?(CE\CK-<YG+;M
M>K2\JX-1;-Q+-ZFL9V<%L(GK^V'L%W]#KT;DIBS4ZJM'I#C5*PH'N516I1NC
M_P#5?N\ZD.%.O(-9,;>)MS>[2R60]F[G+[$MMRZ#BZV-_);%K;;9HEH.I6YA
M7S14ZLB<:UW9CO6E34PHH(G:!HVXP\D_?G>).6,\^E=E7Y-S1U#\=/%<OM:[
MW"-2GJKGOI7DWH#EFR'&Z#'9;TB2PULW5,HX%9FE\>CIVK45O7CO)HFT$E)U
M&Y>6>G>?()>-;Z5:O'+*H_QF)_[;[/CH@4P@?/<BY>M&K98VI:;4I()*;/G3
M@>I+Z=L6RH2S6WT594;;5:!*N+@9EO6<],J-8)2J*7C0'^B(!100X<\IN=T?
M]-**OXM_DH0L2QM97-$:YQYO<OB]AKH=;Z8 5?Q92E++ +^@UY W'REW/'CG
MUMV4VC#M['MG\ "\!A\8WOP_?S6R=/C/NAGZ?F/0E=05)&):'Y.J%L>OYLV6
M44D/9N*HSRK7U/V,C+C^I 4@]@LD+$H3+V(]/M>]%(TYA@30%)A%DWQ53T_*
MG==_%=VV91=E5]-6BVB[5E*3FF,W$N,L2G(W5?0+O!>T:KM>Q+M9I[#K4=;@
MDUCBK%B?U)+Y)&V,O'L',33HLTXL@)57?C?;^&XSFOG&;<M4%\AD#<V/41J]
MXN_H>P.;(PAE.Y(W1VDY/3L)-0I&--MR<5,20'6$CD"H+2,10DYQXS0E@"<'
MQ,93$S$\Z:%.9N"NL[GXH97>DZ8EE-,5N?&ER)"9 Z./1S8J7]17P3>-)6X5
M?C*H*FCBZ0I="*49'H@MQ>RV5Y"<[@:DZ<9#>2/<=)RQC*IY3]E\9E\=?1$4
MZ6?$U0TFX@ BZ>Y2FW*W7K;>J=NB_*O(E6$5>&Y.>EU:O<WU/W-5)PQV7$'-
MJ-I=6N8FS+W;HL*,3#V36=T5K/+AW4FY_P"0.M;Z9)=.>4X3)**FYU@?,5%I
M-U^ZWF#39:37/[*OFNZ+IY'#$<F<)Q'C8+9X43@4H.94S=&@L_UDVJ#U2\9>
M1J9QC_+6--%HJB^+F\']JH^*S>N+8BE0E=BU;8U[4C,YG2T&A;9!(GRK>=;3
MUXKYLH*W)N)]CUASV3QU'(RE*Y(X2K:<2]2@ $Q6(PDYQ'#C2*>I^=^AN=V&
MJ&ROGV+P;J;H[NCY%>=H%7R&?M9DBDG)_P B-CR=<7<;.R,;@:XN!W/(D<<F
MI^MDBVQ%E'A5#(\XM"&,Q-WPB(^\-M'R(<>VG,N4N:*+YD:5[[7E$VC4GYPZ
M?3*8>M=+/H6O8%)8<EB@6RS)+#Z^GRI@?E+(^&,LA=F]N>!-6]&'>MHH ZQC
ME%S,\6N*2_&QV$H7<;O<0@4YD4)YRB%?IK^@EQ75!F2QNQJ_'U:99T2YJE26
M SV15BSM''T;0E2!C4+W-2C>M#(C8E9Z/WAHC>['7O\ C1C3W\:OR&KW7L92
MQR2U(Y>\]9>R$;!=C),:BB=7=!0VW[ (D-60:63YHL1?T$TO[9 $R=C80JHN
MWH:_4$':0K1(S0"-AOQTZ:)MN'E7I@,89UO*O!LFJB)S;XZ^X^+DW/RN\J58
M%E*VK=TF@<EAEG2Q]1V=(XZ^PR0'L+H8->SKG-_)4F%"/2%;4CV74B8_]3SB
M6!S7XR>H&DWL[=2TPRQZSNA^.>'H]'KQC\Y@C.X+);2RIA1=9T(_NITB0RYN
MD'0$<9RDI;L60;'G$HD(5Z]-K7CLN^-+X1,_PP1X^./J-&RUJ/?-UPWU2H#.
MO"&SE6=V[0M"CH*V+?B=/MM27+#V2KKDDM:LU:Q=RBLE F0H'QQ>XTJ?U3BW
MH?.H] $-\===&Z#XTR;EK:BJYY*MRE)! UG)_-?*5;.]EN+JF71.S[,5U A5
M66P5[[1![-[8:O6)4B%6\)UBA(M<%1I!00"2F^-<\JF=T<YEIFG/QF_)##'>
MPWBAT[2:IYPD-D4+PB2X7*F0(7_E/KIUOMUNB33-,K<  :I91/YW(H2Q)UP?
M=*BZY)TE^XI!YHZ1GA/'GQ\EMFGXZ;Y@-\Q3[$Q@A72-9_('P]:,%6N<\9SE
MI7/_ #Y\=#GS;+I)MJ6N9BY,\!LT119B#0=+%PCC%@0C+V(S*F^*[U/ZO5?^
M%>F%OP--7#:6$-"KI1'7D%83X.&PF=E:C7-BZ!8)\YH2[(0JC&QJ\8NWFF 7
M)S!&DF>'I:V=H(=B,H_MW<E+Y;\=G9DC3R1UCM 2BJN573K]UL(C@=+8M.W-
M)&R(G<NLE7JK21-,WMIEHU["\7FA7R(N.GRI.)$8NT]%!^LP:)U%W8^=<6V2
MS^1[ID?QI5#444D$SD75?.4>HNVJ:?K=EK!N;N=Y<^.K#,HM%[+F<4<ET27*
MI@G9SXH^.!*I6WGIG)0<(TX&]F"K$91&5\FL*P/CGZ\%%XC(K.H-?U+([6Y^
MZ9E4TK>&W^QP!/SS\B?25M*K03W*![D4TAS8[1JO(HY-T,:I&QG.+U&T,6+,
M;4(P+1[V;C.+TTU_#V+E^,OKP4@Z!>X= F"7W[>'QZ\:UF]]8QV:1&+.DFO2
MC9<IUUS$G]0]O#%-T#EUC7($32D=BD@VL\DG1+FH1%E['D2,\=+X7/UY(_=?
MCDZB0L]9&[YNN*^*3*6];@1<HSJW*$H05#VK;L,IYJJ.Y8:R5;<DFK5FK:*N
MT4DH2$*%]<'N-JW]4YMZ'SJ/0 7=CUU;)C>0NC2/BKX9Y@0,:0B\:3=/CH'9
M;,CF;0B1-R&@+AI:47%I+)BEQ+6\$-T:A[F,!1!H].6@:)*"/9H0[L,;HWS/
M+5$'-/QY7K3W6-+=#J(D-F>%?8'R<2WH"4E6MMU/>^=+Q?K(D',C"J8MR%4A
M<V(#RK8W EF2IO,QK]F'F%E&B4"$6<HG&NT,.^2?XY;5NWH;KBQZ8YRC4S=N
ME_C96T%&+82RJ 11UB%]LDMF>E?VI,D[\T2%/J?5@]-#*C=6XA864!L])7M.
M4 !@H8Y5$1,\V&WG\:?3; DZ'@] 0Y:1S4^=<<D76W4BUSN,RK5JUI%N<E\,
MZ$:D<.M:=,T/='9;=XVF2+V:3NS6W2M2SC.-/&<8'9M6,HNYXU*V$[XWOYZ^
M&26\@0W=FO%U/4-5L\1:K6F\$C]BL+<LNLN7M$3736!3!_A3$5"X1L*%JTA?
M%ND+>D3)=*C32O/LD91_9<\$ ,'QDW3471!MOT;7+?'!PSY)5=E5.<IN-W^H
MV/CB1<5.<5F<7"RJ90Y":HG..I5^UKZR%)1.2Y0/ZRV6/TRAA+NB8J>GYM5.
M ?&CW-*FV1L\UI/=90^SW?XYY%;L 8+'JROHLML"E>L'*:=2OL+:*GL61N0&
M =2+Q)FQ\='@^7RIM*++7# JT4G+FJ[L?U3KKXGK?D4L8X!-JQ2N7-%=V-\M
M"ZLH&.WAAC\<@?0)5*K.265$SHI04X 8DK\P/RM&VF"$3&E911PBR!Z3[#3?
M''GI_+P&[X^.[W2YN3I9<BFVGU5#^?\ XZXXBLJN972<KD?/]JT(0WCZ8;I)
M)K.LR,R%!'[(?DYJQ^<XB@DY\W:E1[<L*\2TOF&[&IKNV9\#<;3_ )UY%M2,
M.J7\WW45PR;HQWD,U/F2V=F(5+[:MOJZ#7)W+3H[H6]DAD"D[4-*VH DE(_$
MP(R_<[.$(QEE<]FCV%?%UVR=!WY&P\GJ*/G)7!%2\\SN2._34,FCA?G341["
MH.V+5N9&Y(YJ\K&EKL2)05W=]N;D) YN9@M)5B8H9271ITG/'K>O[+579\9?
M3#PU7W/V2'+9))K&^3F<7!-X2FF<2F+A;7$!K&]'0*$L4.L>>1BH#4#':C\7
M+%$0>5S,0Z*T0AJ31'@2E"C,9X\.WY9WS-PE<U;] 4RX=&4):_4]0%<Z0:J:
MCDMK6C4"V1<9.I,XNQ5:C58M=HK1/BLA1S" 3EA;D[Q%3Y4X :V8IH.V(HO1
MHZ3E%>F:F_NI(B^*;K6.4+0%/@H&41R!U<3V-"K"A-+2+G9W?W^V+)G\<<J5
MZ^KXB?VW 8B0K1U@WZ8&UZ<%Z*:0U0E"8G;!$F&&;C4YXS-WKHGLOX\.P3NM
MZ^EDVHY]MB31+Y$J!Z06]QRR^H4$Y;RC!ZCC\3_,\OK#4J ]F3"$2]"K4*&Y
M*S@9#%)AKFA4F*%'IBK.[';QY<%N?DH^/.RNM+QMBQH_ D<I3M_Q@7I4-$NP
M[$^QBMD[!=[':I=4+DF*2/K,K0+V$2#2U ]*O%"UJ@^?S ,\-X3#*(BIZ_A#
M8^$^QG;OI/==A"M9R1&3*B9C ;=@C]2BYKB$$B//<=@MH4193O,;(9K29H/(
MK!3OI[DT1J//39)!OA;D,\E848(@N[';4*I._P 2/5T:H?C6&BB%COI;;RK+
M8MT#'*QG]53>SX)V9) UZ@;[^C[_ 'G;,%A)3RR0^* 8F63LKHI<8@2VD 0(
M1I5!^M1=\7/C^%SWOXV+PM#J!M7W=%A6-SRN[N=;BG(GRR4244TJ,/QB0GGU
M&ZR6,Q]\0J%@'OH>/F^_82R]$&B\RL9 D@_$1G?$1IQK]U^_CAAO3U&\Z\Z\
MXW_7*[WE<4$61)[;76S'YR<5.&VP'UE8:J&W%*G&1/&VRM@-ZT#YM2:C]/6D
MF][/ +>5,IB9F8:]V'XQ;)>NM:^N*SJ4@,CCL9^6#L#IL]^>'Z+.SBAH&RN>
M"VJJ'I,BTM$M&K,O)C:5OU6$.UB)4B)5FEA 7YL+NBJC_P",0F;Y(^ +(ZXN
MR=S-KA0)9'&GXSNG*MI\TRR3X<!H[&DLRATAHYX*;D<@9C"'1CVT*%2!\5!$
MD:%(=&><LWR"T,<ML=[_  J_/.'.X9'>RV5+JSD$ENJ06UP]-Z:[=W?K*C9N
M6J=J:)4VBZ3IIYK\4P2REX52QZBLRT:B9V5T9IJ*8Z/<51.TPO2+&6-=M=.J
MY_?G-5YV1V'Q;>5'UL]V4Z51(HVU21+9#C6#ER[%(*XVQ#Y!8$[5L#Y/8[;<
M-Z$BD6835,7D47:'O2H6@MRLH*<PW>$QF(QF):ZVOA3Y*W&O&&G(Y!E]/R"C
M>4OE-I*'7ZKO2('I9]9?4-PQF=4?)8@CBT@=IM&F19#6@Q*)W<DB-U8%ZD>@
M)@A3@..-;L;OO#*Y[\8<IO1F0G1GB-=SA%8/\</8U0UM4DDNN%JG>.=CS>4U
M9(JGF9<DKFS9&D>Q.;Y'%SDBD2]=YT:U,!<K+3*QE;"3=$<[FX7_ .XN>>C;
M<XOY/A*2#.=YR&L[/YDFW5E#)[)9HD[="U_!8XI26I7OVR?'Z/Q%_4FS)4C>
MQHG-R2-C[MIVG-.\IVM",XS$93/+DUC1'XT>VVRF['CT?J FKE,LHSYM(]#Z
M[U>\<DY\/D?94TJ"0<J15?, OYY+RXDL\87)SW89II;08FWHTX(30"&Y-[\;
M^WXXI$F7Q@]"QOI6IU,-;;6*IZ/POE0RL)K5TGJ>32[GFT8/9#S/.D7622"\
MK2CLN:R+=D3KMUD3M&DLF63% <I:EI&@@2A$3?%:\=6//?QMW-,^'KQINS>,
M";'ZR:.CZRO"77=*;2K.4MW:Q<0ZN5V"[+8,_22?&/\ #'9?SXO<F-.URE!'
M6]M+=/JHDS:8.S0Q=\1E$Q.GZ,CEO!?3FK$>9A/N7'GH'EMRZJZ9L@SC!AO&
M!11S.9[*Y\YLA'/=A':<[#C5=KTU0OE>R=C$SFO0#60;F%X;BE(RRQ82,L:J
M)K*N*/I;\4W;<QJ=Q7V(299'2,!^-_E.KJ3L %YKDRR.]75ET%;L_?UB)_6O
M[.I62>!5S(F)K+F#F3H;J$I3H)@O<*0#+OQO3A?X;B.Z>?;=NJS>09! $4J4
MQ"KWKI]3;2F!SYF@,[0LMD\A7%545-A"]Z<6]$9,#YW+4!;8H'O9#8M$6M.V
M622,P-8QF(B;XZ?J@CX]^9^B:@X/Z$H&>5>SU^Y+5-H1RA2EH*]C]N6!$'2I
MV&-QN<=%:JZ<3ZK$]R/LJ3J2'!R:G<9;@F3IURL!"HX\.#*8G*X:XF[X>N@8
MM $!\/KE0T6=&>3?BR-BKHFOQ>-2W=FTS<>EW7]BE*%TV.;=S4VI429N^OS
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MT-D]8I&4F^460V%TIR96E*5M:L3JN8]HVUS?:=L3F(0,^NK%6TM1=VOEFU]
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M'3'X\O)OEPYF P& P-"5H_\ )(Y:_P!J^Z?U]$X=(^*?%OMPYF P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M+R;Y<.9@,!@,#0E:/_)(Y:_VK[I_7T3ATCXI\6^W#F8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# T-=Z_ZU_P 'G^1[[_42SX=,?CR\
MF^7#F8# 8# T)6C_ ,DCEK_:ONG]?1.'2/BGQ;[<.9@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#0UWK_K7_!Y_D>^_U$L^'3'X\O)O
MEPYF P& P-"5H_\ )(Y:_P!J^Z?U]$X=(^*?%OMPYF P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P-#7>O^M?\'G^1[[_ %$L^'3'X\O)
MOEPYF P& P-"5H_\DCEK_:ONG]?1.'2/BGQ;[<.9@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,#%IM.(;6L2D,^L.51^#PB)-2I\E$NE;NA88Y'V=$#9BMR>'A
MS/3(&]&0#7WQAHPA^[K7^.]8.+RU5J5@AE3%!%UBP5!.90CTXQJ%+I8PHI?(
M$&R1J-+&:,JEY3VYIM$%"'L9) PZ"'>][^YO!4L]P/S8M!UXBWH.O$(?'>]:
MUXBWH(=?=_ZB%O6M?]][P,<B<RB$]9]2*#2N-S./[<7IGT^Q-]:Y$S[=XV\+
MH](FK3FSJEB+;BPO[8I0K2//ZJ58G-)-"$PL8=#AQ9)@,#$6.?0B322:PZ.R
MV.ODLK=<RME@1MJ=T*Y[A3C(V)')V!#*&Q,<8K9%3U'7 A<E+4 +$>D. :#6
MP"UO8J678'66K$C<C5N"]20B0($QZQ:L5&@(3)$B4H9ZE2H.,V$LD@@D A#$
M+>M!#K>]_<P/"ATTB-A1&.3^"29BF$'F#&W2:*RZ-NB-XCDBCKPD*<&I\97A
M <>A<6IQ0G .)/*&(LPL6A!WO6_'!PTEDV!B'V_@_P!O=59]KHY^<K<0W/\
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M>C3H]+71>/1JYR5Z3EEZ4KUIFO,:</S&&"^Z+>]X'?P& P& P& P& P& P&
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M&ZG^AQJ>SW/:_P!RI^,_B!_!NI_H<:GL]SVO]RI^,_B!_!NI_H<:GL]SVO\
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8# 8# 8# 8# 8# 8# 8# 8# 8# 8# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g137834g83m44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g137834g83m44.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1" -( HD# 1$  A$! Q$!_\0 N@ !  (# 0$! 0$           8'
M!0@)! ," 0H! 0$! 0                 ! P(0  $$ P ! @,"!PT%!0,#
M%04" P0&  $'"!$2$Q0)%18AT]87E[<8,2)TE%58F!DY67D*.D%1(R1F,I75
M5]AA<4+P,S0EM29WD:&Q-74V=K8W.$-31+26)W@1 0 " 0($!@(" 04! 0
M   !$0(A$C%!46%Q@9$B(S.A _!2L<'A\3(3T6+_V@ , P$  A$#$0 _ /\
M?Q@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#465YX^)4.M!K:]V40L+8JM]\ 6XH"Y3BQ82OI<+C
M<6' KD*N2+%)M13J<Y(&""3%V;GDVWF8\1U4=_X9UMEA6?J'>(DDM2@D3IY>
M9/Z"*NABMZA<F[/,A?*\U(S1'2XUA*Q>>NBZ69YJ3@+8L8XT\/( 7%-ZGLQ_
MC->\;92[]M#QWUQ0#Y#.6FWQ^46NPU*K5(S+XUVN'8+<<OLP5 I$6I<\E<\9
MZ-:&+=*-Q4C9$ 3(C3=/:4TXI.E*T3;-US?SG_FSXM=4(U0/SSL &UE[R:K@
M*I"1@VR;*'I5MY7([8 GP1\@*Q+76YW,H;Y+9=2$BF5,.Q79")C:XZ2[<H8$
MI]0'P["6BW4HKW*N0K51 %RM%I!/";9\^- <][&YP"Z$FVTU]223-<Z^UL+(
MU$V^M+VTO:3N,I+VQMR8F!]1/Q-*/OPAUUO\TG'ZA*XO]BQO'CR/>/RNI#ZV
M>N)>EC ".2[-%BP&IUF:2)?*L/-#8327I2VD.LJ<&W)]]?42\,DE#X:7W .*
M(5GJ%/XV6;/5F]UYC70+[U.S\0J8X=..54?!.!2O7:66KNS4%R2$CE1TAAZ6
MVII7H-N7%EXGG=XPE)\P97[K;+=+&TN3T(IJC<6[C>HXFIQK+?Z=HB7FT_FY
MN$*DSK-RRP0X<*0XU.G.BWOEF74^S:AMR71Q7M?./(;G%=ZWR0R3L7/;;&3/
MK-@)5&Y4O1T8ZVV]$,#!=YK]:-2PA&.ZAV)-3&W$F,K2XPXXWO2MDF)B:GBM
M7"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P./%9\#N#V:
M^^2\CFWD/:X_3YOD;0N\TA*0P.9%\;+1S_H?1+HBI5*OF!D<==N:V/N5^OTP
MPRXM:')QR9!:DQGX4=<>--TZ7')8/-/"'F!:8X4$]OM-VN=5+^: /KMM37A(
M^)<NL^6;5)_.@5B18L.,!#L\\76H<* .%JE1X?P_E9KSLQE]:JYG+MT_#"SO
MIK5^#X(5+P](]6$- N4W#FW2!5T%<<@HA$(G(C(&S#H5LYS$M<[5G<L#E97]
MIO19L5Z8M]6V&VMZ2G"[_=N9OQ X+XRC^E\=ZMRGJ4[J5OXSX9"/%$::L%1;
M%'C]" 7<829N<PH]7@#J']& 4B VQ%:U$0E3[:=[VVY@RF:J>%VHWO/TJ^ G
M)MGLM[\A;-1;!V/L@9=#LK0^M0IPBVWSRJ[!Y"D>< G7]+0?&=1A]B)5"7!?
M_P#I$"-'EI]LQEM:"QG/3E_HM&X>"',>XE+-&IO=!1&Q\T\\KMY*6B 9I 3H
M=>KG3;MPR/4IO*CP%L[7]K< U"Z1#,9W4Q$R-*=84ZA2=*;V3=,<N2(O?2F\
M?1MKN;97JADG'Z_U\#W/IM">#BR<JY'M^0/<[\*G-LQGY)NN5YUCR"<K,F3$
M0W#;;#0R.]LS$R7G"[YGT3KQD^F (\:>B<WO@[MI#H\VF<"C\,,D;[S\#+O-
MF8'VSNEO7<Q]S%&AR:T:,FNZR=EVT#Y;,[4!G2?@;<<WA)SOU;O<FIE/\3/&
MSEG-#-U2[3>#<IH/-MW>S_)BGB<"E5\14!I*>Q'5\JT4-NQ&4HC,>[;DEY++
M*5*4A.SF;RFUNUJSA+>%@6 !+<EBB:9"H3TB"0%R'-19+L21IP<6BP249;,A
ME25)=90K7IZ^GIO6]D>V 8$%-R]#"HTCL>1DAY^H$Z++W"+0T)7+%R]1W7-Q
MB,5"M;<87[74:WK:DZP,CZZ]-[]=>FO7UWZ_@UZ?@WZ[_P#9O6 ]R?32O=KV
M[]/3?KKTW[MZTGTW^YOW;W^#_?@?WUUK]W> ]=:_V_\ R_!K_P##O _.UHUZ
M[VM.M)UZJWM6M>W7KM/KO\/X->NMZ_\ ?K _ON3K>];5K6TZ]RM>NO72=^OH
MK>O]FM^W?X?_ &8&(*6*O@Y(.$;.AP\RS%OL&MQ"A.$/DV$Y]G$"_P!C V);
M[+I8M]DB94KY=C3CWR\9USV^QM:M!E_<GTVKUU[=>OKOUUZ:]OKI7KO]S7MW
MK\/^[ >NO3U]=>F_PZWZ_@W^#U_=_P#=@?W 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MXZ)K^SK=8_,P=/C&G7#E2\H2_98!B7TR^/.&0);J5BNC#Y.8I.I*)D 1:?\
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MIBKPTRPLA0IUAWU:2CYHMXI%$\9/*4 #E *1VT33XI"!9H2E0B1QR,"DQZG
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MS4,>@(7UMU7KJ-J2I*4*T^YK"1->JD#G&O-&,'*3:EV0HJU3X,5"HUBM,$B
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M1(VWKP4U: /G,6'5RK')5EL(IXKR(C.+@(_' Q"669-<,LO18%S=9D!5BZ(
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MYIN8'T"W2!5CLFW)<2![9&PS3Z')3&O?.$[7\ITKRJ+<[[!8S<[I->NLGH7
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M*B^RI35P\VR4EL=('&JO\(O13%@DT[G8,FP)HS1WF1XRJMF"QHNBT6^?&(6
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MXNMF!4A-C0Q(-N IWHRHI&9CP9;JG&V&]IC[>>),1"]L(8# 8# 8# 8# 8#
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MRJR0>37?MV&E<1+\A]C1=FFDKN)?6)8A2Z\)#<4J?1C9OC%BZ7(;YQWR#*K
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M7-=8?KE6L *;$\>B%;12S)#EJIQKJ9D?Y"L255&=!%2H\:MF5.24N1=LX/\
MS[KBHGU)[?W8H9J%:Y9-X'-!]>E@2MRZ/+A6EJO\KYU&ZA9.NV*Z4^*T"*T6
MT Q'+XT-R#.VY%;<M@Y<>9)4A_31-M=VL?)OJ;=NM);Q.^/;@O1^0]H[7U4+
M$ZW1.>U2+=+U11G3>-<\Y4#M/.Y=X6S0K'/$].(7&P#AR7[,,HD&*5D0(6V"
MK"3J<(UZO-0?J7^1;W3N5TJP%(=UYI8/+.Y<R7UFAT?GIB;T"HCIOB\!I]4K
MI"O]"*\QM*IQ/NQLR8DU*64-!JU7)'S$9N:),ZU"<(J^=?\ U*>[_4=\P*!8
M.(E*'R(X?IW2AGD+T@6T[PCIYT;T< 1Y+Y,7KQ2YC6+E6X,@(&L<$3Q<&?N2
MY,A)!;-GC1X[#+#4N0R(QQGC+-57SL\N?EN4V<9.H'<N<RK#YLU2,;J/*SP<
MUY+N\0\?;%V#E-MHL@?9RH>L@9UK!2*N_'AQYJRQ&*I;#S6O5E53;CYZ*4Y)
M]3SRJN?5_#FF.SPQ4)TZ["JOU<L_S.LH$V0F=Z-7 IY'+"=6OA9%YI%4K-A^
M6:E5MPF3J1.)*D6Y*($5QQ99PQJ7^D_#(P& P& P& P& P& P& P& P& P&
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MB,O58*T %&AD.7*E3H\&!"A(5M]$:-M;8B)O3BS'0+3XU\]M$ ):.:CG)-G
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M\-U:4N8<U-J>MO??&6'SVW$ZWP9VP%@=>D](&TO?(X ATD#Y;3&AU6Z3)4W
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M& P& P& P& P& P& P& P& P& P*%G<,C347!'WC<:^]G>>==Q]4B&5?9K]
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MD4,0C=LVXZ N,Q)6WSA:N@4Q^6_IDN/C#7Y2/A>[3>V6]I+N=$L.# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MHG3@C?QP=G$P>KQ0LBF@SW14UB(^F2TN2)CSG=,H4GXBDI=6DD1KJH.X=O\
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MM;:95ILDMA<(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQ*8P,[!6R$N"!AGIT29#^.L$0=4XXW)=BEO'5L[W)WR'G/<<F\*I-TU6^<!
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M+^SD,N_-.38SGQ5J;^![4:<66*YRCO+;EYP%KP(@=DX%XWT?G3S1+9RS<_\
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MWK-I[P^O=9/*LZ_(CQQ\;>9+8K JD557)^@D>N*-TIU,_1BHGU6;AG(]@JQ
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M/IE/LA.?';C;8TZ^E1:CK/HOWL/-B53*A2OC?R#BE[N$!M\%TNO](\G^F<=
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MYSFE>>- P5O9.S3A^.@4QZ/3X[39ULQJ_P"</RO_ )?]0/R3Z)+X';94CQP
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M"J,R7E(J%U3,;A3"B-OL?*:6Y&4YI"O7]XHL336FH>'5\$57I//[1(JMQ'V
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M'OYY7BG_ $A^1?E?@VY=)/V[_![^>5XI_P!(?D7Y7X-N723]N_P>_GE>*?\
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MA(':*R1L;+L$^RIDS/KMV,07I"/:X[%*2FE;VA]S2B^^>-O84Z!](,WR*O<
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M]IB6 -.@LB8GR[C:F!K>HR-Z9_>87WU6M,M9NJ?24NG507<[AUCZ?EJ[)5V
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M--'] _H$OU6TW*%]+_D[H2K&O'^M/[)5+Q:JQ!\]Y'U+GEUHK,T9;^Y@)U/
M0PO2X&IY^P($5[4IF2Q&G27&?:I3KY.O^6VEK\'_ *)M-Z]Q#B1GZ;? FKGW
M#FYOK V2J@\:@U>K4FM,CG#\PI9#%[&#[D4$J*-J>'T[=GG(AH<G;:U!2F2J
M.;SF+N6NUKY?]#"D\SKG8+3])>N >>=!I%DZ9R:PF>)<3#M]1YW7E473=S#1
M"?4HLVI!#[/11DB%NTM@'M0G=R)+<=M.]Z:+\EUNU9B%R/Z!2N@.<N.?3@XU
M7+FV.\:2Z&I'*^06&L$AGD[;1=/KL^N7ZD7VTT:UPN>R[ +EVEX80E-0!Q6+
M(BJFH<5[*?)QN:U_#^M<-^B4^OQ[>_JDJ0)!^59YV#X^V:Y<Y\;.>!>DU9 T
M08CW\;]_.U5TJ,"&A9Z)(%C)\6):"C4AOY44XK>T:%YZ^[@V4\8_I\?1<\KJ
M[=;=SGZ;O AE<IO0K3S=4RU\SYC%)%35-+3 9UURK ;58;=2ML$X#B4C[1
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MY>"@^+WT".D7GCG,:WX+>-#G2>TW3KM-!T%_F?/OO?6=<:WV%!ZUW8#$/2R
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MWVD].JU:F2Y<.M6CXDOY)_Y1+36XNW$H2GX[ONCNYS_7.[C%/]+^5D8# 8#
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MOZSZKN^B1Y2>1OEIXDWZ]>4MUKG0.J47RH[]Q-ZSU6FBZ('GA.4V"!6H#L<
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MCZI\7>W#,P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!
MP:\]?[:_Z'G\!\^_U$A\-,?KR\G>7#,P& P&!P2ZC_J2/%K_  K^T_KZ9PTC
MZI\7>W#,P& P.:_0>!]5M%K\A=;&S8S=SH?<AZ+PQT5(1%V%W.KT^'QFCQV1
ME@A6&L[H9L)/0Z_(9A0HZ?BJCO/Z)3DI.XF-&VW)A5G'VGK,@HW)C5Z:;IR
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M:<)=?]:]-:UZ[WZ:]/7?[N__ &[_ /;AP_N P& P& P& P& P& P& P& P&
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MMIAIA-,.::C.NNQ6:YFN2ZL(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M$H]23,3ZMK<(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MM?X5_:?U],X:1]4^+O;AF8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M<T#B_2>\4H%?:J(Q_L@NI1@J68-:@=?M;(V!?-<DB<(=[-&<V\LCOJDKD<)
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M%?@P,M@,#R:GPU3G!B9+6R#41F>Y#TK7QT0Y#S\=B2I'[NFG7XSB=;_V[1O
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M]1(?#3'Z\O)WEPS,!@,!@<$NH_ZDCQ:_PK^T_KZ9PTCZI\7>W#,P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P&!P:\]?[:_Z'G\!\^_U$
MA\-,?KR\G>7#,P& P&!P2ZC_ *DCQ:_PK^T_KZ9PTCZI\7>W#,P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P&!P:\]?[:_P"AY_ ?/O\
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MG>7#,P& P&!P2ZC_ *DCQ:_PK^T_KZ9PTCZI\7>W#,P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MEPS,!@,!@<$NH_ZDCQ:_PK^T_KZ9PTCZI\7>W#,P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MLLG[BQ-.V >ZW!=MSL.@1ZXU+EPT*<DQ4-+6O>WEJ:4M,(G7LN (=E5/@?<
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MOIG#2/JGQ=[<,S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8'!KSU_MK_H>?P'S[_42'PTQ^O+R=Y<,S 8# 8'!+J/\ J2/%K_"O[3^O
MIG#2/JGQ=[<,U>].2MVKQXNI,Z*V0N'.QDIP<0G"I:X!._UF 0C-SQLB).CH
MF0I#C3GPW$;4VM2=[]-[P0_/YK:A_P!5?I!Z!^4^ _-;4/\ JK](/0/RGP'Y
MK:A_U5^D'H'Y3X#\UM0_ZJ_2#T#\I\!^:VH?]5?I!Z!^4^ _-;4/^JOT@] _
M*? ?FMJ'_57Z0>@?E/@/S6U#_JK](/0/RGP'YK:A_P!5?I!Z!^4^ _-;4/\
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M@EU'_4D>+7^%?VG]?3.&D?5/B[VX9H!TC_\ $ K_ /3_ );^LJJ8$_P& P&
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MG'_ROPFS/I/H?UG_ --O^?UX;?TE./\ Y7X-F?2?0_K/_IM_S^O#;^DIQ_\
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MF2VS,'F]Q&W'YE>MDFN^'/*@,]BKWEP,W<>6-FSXB\?97D6=J\&>'"4L+!)
M0*^.#8$AAI_4F2X=82A[U0VJ8*[IIV\36PF@<H)3J!6(Y+ACERY^_1O'FFW
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M0I:78K2].-^BDK:0K6]*0G>FI\7_ .DB^5_S*G\I_2!_BWE/^)QJ?#W/E?\
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MG&I\/<^5_P RI_*?T@?XMY3_ (G&I\/<^5_S*G\I_2!_BWE/^)QJ?#W/E?\
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* P& P& P&!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
